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Joseph L. Wiemels, PhD,b,c Amanda W. Singer, PhD,a and Mark D. Miller, MD, MPHb,dLeukemia is the most common pediatric cancer, affecting 3800
children per year in the United States. Its annual incidence has
increased over the last decades, especially among Latinos.
Although most children diagnosed with leukemia are now
cured, many suffer long-term complications, and primary
prevention efforts are urgently needed. The early onset of
leukemia—usually before 5 years of age—and the presence at
birth of “pre-leukemic” genetic signatures indicate that pre- and
postnatal events are critical to the development of the disease.
In contrast to most pediatric cancers, there is a growing body
of literature—in the United States and internationally—that has
implicated several environmental, infectious, and dietary risk
factors in the etiology of childhood leukemia, mainly for acute
lymphoblastic leukemia, the most common subtype. For exam-
ple, exposures to pesticides, tobacco smoke, solvents, and
traffic emissions have consistently demonstrated positive asso-
ciations with the risk of developing childhood leukemia. In
contrast, intake of vitamins and folate supplementation duringsc Health Care 2016;46:317-352
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exposure to routine childhood infections have been shown to
reduce the risk of childhood leukemia. Some children may be
especially vulnerable to these risk factors, as demonstrated by a
disproportionate burden of childhood leukemia in the Latino
population of California. The evidence supporting the associa-
tions between childhood leukemia and its risk factors—including
pooled analyses from around the world and systematic reviews—
is strong; however, the dissemination of this knowledge to
clinicians has been limited. To protect children’s health, it is
prudent to initiate programs designed to alter exposure to well-
established leukemia risk factors rather than to suspend judgment
until no uncertainty remains. Primary prevention programs for
childhood leukemia would also result in the significant co-benefits
of reductions in other adverse health outcomes that are common
in children, such as detriments to neurocognitive development.
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ncer is the second most common cause of
eath in children 0–14 years of age, after
accidents. Leukemia is the most common
cancer in children, representing approximately one-
third of pediatric cancers. Approximately 3800 chil-
dren are diagnosed annually with acute lymphoblasticleukemia (ALL) or acute myeloblastic leukemia
(AML) in the United States (U.S.).1 A small but steady
annual increase from 1975 and 2012 in the age-
adjusted incidence rate of childhood leukemia in the
U.S. has resulted in an overall rise of 55% in the annual
number of cases during the past three and a half
decades. Modern treatment protocols cure 80–90% of
children with leukemia with fewer sequelae thann open access article under the CC BY-NC-ND license
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FIG. Incidence of childhood leukemia in California by race-ethnicity, 1988–2012. Adapted with permission from Giddings et al.7previous regimens. Still, even with improved treatments,
the immediate and long-term consequences of childhood
leukemia continue to exact a heavy toll.2,3 The impacts
and costs of childhood leukemia extend beyond the care
of the sick child; affecting family, friends, and the
community. Long-term and late-appearing secondary
effects include detriments to neurocognitive develop-
ment, mental health, endocrine system function, and
general health.4 To avoid these risks completely, it
would be beneﬁcial to prevent the disease altogether.
Though new genetic risk factors are likely still to
be discovered, to date only a small fraction (less
than 10%) of childhood leukemia cases can be
attributed to the inﬂuence of genetics, including to
genetic syndromes such as Down’s.5,6 Moreover,
the aforementioned increase in childhood leukemia
incidence—which is not fully explained by diag-
nostic trends—indicates that causal factors for
childhood leukemia have become more prevalent
in the last few decades. Since genetic factors do not
change on this time scale, it is probable that
environmental factors play a signiﬁcant role in the
etiology of childhood leukemias and their recent
upward trends.6 These facts underscore the importance318of developing an approach to primary prevention of
childhood leukemia focused on reducing exposure to
environmental risk factors for the disease.
Children of Latino (also referred to as Hispanic)
descent have a higher incidence of leukemia than
whites, African-Americans or Asian-Americans nation-
ally and in California, a highly-populated and ethnically
diverse State. Moreover, over the past 25 years, child-
hood leukemia incidence has been rising in California
at a faster pace in Latino children, compared to white
children (Fig),7 suggesting that Latino children (or
parents) are even more vulnerable to and/or more
exposed to harmful environmental factors than others.
Exposure to carcinogens has generally been consid-
ered a non-threshold event and modeled in a linear
fashion. However, there are chemicals for which a
supra-linear dose–response curve has been observed,
indicating that the risk from low-dose exposure may
actually be proportionally greater than would be
expected with a linear dose–response curve.8 One such
example is the known leukemogen, benzene, which is
metabolized to active intermediary compounds. This
ﬁnding is consistent with other exposures of concern to
pediatric environmental health, such as lead, where aCurr Probl PediatrAdolesc Health Care, October 2016
non-linear dose–response relationship has resulted in
worse-than-anticipated health effects from low-dose
environmental exposures that were presumed to be
safe.9 As such, ﬁndings from observational studies—
where participants are exposed to chemicals at environ-
mental levels as opposed to higher dose occupational
levels—are critical to avoid underestimating risk.
Research into environmental, infectious, and dietary
causes of childhood leukemia has been limited,
amounting to only a small fraction of the total Federal
funding for childhood leukemia research (e.g., 3–7%
of National Institutes of Health and 1% of National
Cancer Institute total funding in 2010–2011).10 Fund-
ing for treatment/outcome-related studies has been far
greater than for those studies examining etiology. The
dramatic increases in children cured clearly justiﬁes the
expenditures made to improve treatment, but research
on etiologic factors that may lead to prevention is
also important. Despite limited funding, evidence
demonstrating associations between environmental,
infectious, and dietary exposures and the risk of
developing childhood leukemia is accumulating.
This issue provides an overview of key biological
concepts in childhood leukemia research and summarizes
the environmental, infectious, and dietary risk factors for
childhood leukemia that have been identiﬁed in epide-
miologic studies from around the world. Our purpose is
not to conduct a systematic review of the ﬁeld of
childhood leukemia epidemiology—an endeavor which
could ﬁll an entire book—but rather to provide a concise
perspective of the subject for the beneﬁt of clinicians and
policy makers. The literature cited in this issue spans a
wide gamut. Whenever possible, the authors emphasize
relevant ﬁndings from well-designed meta-analyses of
published data and from large international collaborations
that have pooled and analyzed individual-level data from
multiple studies. In some instances, both pooled analyses
and meta-analyses (including unpublished data) were
conducted in parallel. Because most of these compre-
hensive studies fulﬁll criteria for systematic reviews, they
provide the strongest evidence of associations between
childhood leukemia and its risk factors. However, when
warranted by the novelty of the research, the authors also
discuss “one-off” ﬁndings of particular interest. The
authors are associated with the California Childhood
Leukemia Study (CCLS) and the Center for Integrative
Research on Childhood Leukemia and the Environment
(CIRCLE) at the University of California, Berkeley. This
research group, begun by Patricia Bufﬂer, PhD, has
studied environmental causes of childhood leukemia forCurr Probl PediatrAdolesc Health Care, October 201625 years. In this article, we identify many of the major
epidemiologic investigations of childhood leukemia
worldwide and we rely on our collective expertise to
highlight the literature that we believe will be most
instructive to clinicians and policy makers. However, we
acknowledge that particular emphasis has been paid to
the work of our research group and its collaborators in the
Childhood Leukemia International Consortium (CLIC).Natural History of Leukemia as a
Disease
Development of Blood Cells and the Formation
of Leukemia
Hematopoiesis is a process involving extreme cellu-
lar blast growth, which produces 1011 blood cells per
day throughout life. The activity of certain cell differ-
entiation stages (deﬁned by cell surface markers and
the potential of the progeny) varies throughout life due
to different needs of the organism. These changes in
the activity of blood cell types over the course of
development are reﬂected in the distinct types of blood
cells with the propensity for cancer in childhood and
adulthood.
Although the maternal immune system protects the
child before and shortly after birth (with maternal
antibodies), the child’s immune system must begin its
education immediately after birth. This education of
the adaptive immune system requires exposures to
immune stimuli (e.g., infections) leading to the for-
mation of billions of naïve pre-B and pre-T cells.
Leukemias in children arise from these naïve, pre-
antigen stages, typically leading to primitive precursor
blast cell leukemic populations. That is, the majority of
childhood leukemias are of the pre-B cell or, to a lesser
extent, pre-T-cell phenotype (exhibiting cell surface
markers of normal pre-B or pre-T cells) and appear as
clonal outgrowths of normal pre-B or pre-T cells
“frozen” at a particular stage of differentiation.
Through the adaptive formation of antibodies and
T-cell receptors that respond to speciﬁc antigens, a
stable long-lived repertoire of cells is developed by the
time a child reaches young adulthood. The pre-B and
pre-T stages decrease in frequency after adolescence,
exempliﬁed by the involution of the thymus and the
reduction in size of the pre-B cell population in the
bone marrow. As a result, adults typically contract
hematopoietic cancers (lymphomas and leukemias) in
post-antigen-stimulated B and T-cells and the myeloid319
lineage predominates in adult tumors. Distinct from
adult leukemias, the unique properties of childhood
leukemia cells are likely to be important for under-
standing the environmental sensitivities for leukemo-
genesis in this age group.
Childhood leukemia, like all cancers, is a product of
two or more molecular changes in a stem-like cell that
has the ability to divide while maintaining an immature
state. Because they are formed from blood cells,
leukemias have an inherent capacity for mobilization
in the bloodstream and extravasation. Precursor blood
cells also have an enormous capacity for “blast-like”
growth, and an ability to travel throughout the body
without restriction. These attributes are among the six
“hallmarks of cancer,”11 and the fact that hematopoi-
etic precursors harbor these “cancer-like” attributes
may explain why leukemias seem to need far fewer
genetic aberrations for tumor progression compared to
solid tumors, which need to evolve additional meta-The development of childhood
leukemia is a multi-step process;
initiation occurs in utero for most
leukemias, whereas progression
into acute disease usually takes
place after birth.static capacities via genetic
mutations. This simplicity may
also help explain the short
latency of childhood cancers.
The genetic simplicity of leu-
kemia combined with the young
age of onset has allowed
researchers to delineate—within
the lifetime of the child—the
timing of the formation of char-
acteristic genetic aberrations.12These changes appear to occur within two time frames
—prenatal initiating events that induce some cellular
changes, and postnatal genetic and epigenetic events
that allow the emergence of acute disease. This
research was made possible by the availability of
archived newborn blood spots that are routinely
collected at birth by heel prick from neonates (e.g.,
by the State of California Newborn Screening Pro-
gram), including from children with leukemia. Several
translocations commonly found in leukemias that were
assessed using archived newborn blood spots, includ-
ing t(12;21) ETV6-RUNX1, t(8;21)RUNX1-MTG8, inv
(16)CBFB-MYH11, have indicated a clear presence of
the mutations in neonatal blood at birth in children who
contract leukemia later in life.13–16 Several other
mutations, including t(1;19)TCF3-PBX1, FLT3, and
RAS mutations clearly occur postnatally.17–19
The mutations associated with leukemia are generally
insufﬁcient to cause disease by themselves. This is the
case for ETV6-RUNX1 and RUNX1-MTG8, the most320common translocations for ALL and AML, respec-
tively. Studies using cord blood from healthy children
without cancer indicate that these translocations may
occur at a rate of 1% or more in the general
population,20,21 while the disease is much more rare.Mutational Mechanisms in Leukemia
Recent investigations into the precise molecular
attributes of leukemia point largely to three pathways:
(1) aberrations in a small number of lineage-speciﬁc
transcription factors such as ETV6, RUNX1, IKZF1, and
PAX5 (2) defects in receptor protein tyrosine kinases
and their downstream pathways (i.e., RAS/MEK/ERK),
and (3) epigenetic modiﬁers. Mutations may involve
translocations that comprise fusion genes, copy number
alterations (most common are deletions), single nucleo-
tide mutations, and broad changes in epigenetic features
such as DNA methylation aberrations. The molecularCurr Problformation of the initiating trans-
locations may provide some
clues as to their causes. In the
past several years, many trans-
location breakpoints were shown
to be induced by enzymatic
mutagenic processes—normally
utilized by the immune system to
diversify antibody and T-cell
repertoire—which were aber-
rantly targeted to oncogenesand genomic enhancers.22 These types of translocations
are common in hematopoietic cancers that form after
birth in response to antigenic stimulation. Interestingly,
leukemia translocations including the most common in
children such as ETV6-RUNX1 do not show signs of
such activity and their origin remains a mystery. The
lack of a clear endogenous path toward translocation
formation points to exogenous causes such as in utero
environmental exposures, and points again to the
oncologic immaturity of childhood leukemia blasts.
Environmental causes may also interact with endoge-
nous mutagenic mechanisms in children after birth.
Many of these postnatal secondary rearrangements
show the clear involvement of the activity of the
enzymes that create antibody diversity, that is, recom-
binase activating gene (RAG) and adenosine deaminase
(AID) in the formation of secondary deletions and
mutations.23 Illegitimate targeting of these endogenous
enzymes has long been known to be stimulated by
exposures as diverse as pesticides and smoking. AsPediatrAdolesc Health Care, October 2016
such, there is evidence that postnatal environmental
exposures may initiate childhood leukemia via the
stimulation of endogenous mutagenic mechanisms
including recombinase activating gene activity.24,25
Apart from the chromosome breakage events men-
tioned above, additional mutations include point muta-
tions and epigenetic modiﬁcations. Point mutations are
caused by electrophilic chemicals that are either exposed
to bone marrow cells directly or else they are metabol-
ically activated, and their metabolites are exposed to bone
marrow cells. Many oxidized reactive metabolites are
produced from chemicals circulating in the bone marrow
due to the presence of highly metabolically active cells
such as neutrophils (containing myeloperoxidase, for
instance) and the high levels of heme iron. Metabolites
that adduct to DNA can directly cause miscoding
mutations if unrepaired, or can result in repair-induced
strand breaks. There is little current evidence that point
mutations such as those found in RAS are caused by
environmental chemicals26; however, the most common
translocation in ALL, ETV6-RUNX1, appears to be
strongly and speciﬁcally associated with parental smok-
ing27 and home paint use,28,29 which provides some
credence to viability of this pathway.
Epigenetic modiﬁcations are a normal part of a blood
cell’s development from a stem cell to a mature cell.
Changes to the usual epigenetic programming can occur,
however, as cells adapt to new environments. This type of
adaptation is the essence of the “developmental
origins of health and disease” initiatives that seek
to understand when such adaptations early in life can
lead to later disease risk, such as the demonstration
that starvation in utero can lead to obesity and
cardiac disease risk later in life.30 Adaptations can
occur as the result of exposures to speciﬁc environ-
mental factors—for instance the speciﬁc demethyla-
tion of CpG loci in the gene AHRR has been
exquisitely related to cigarette smoke.31 Likewise,
methylation changes have also been observed in
response to folic acid exposures.32 Our understand-
ing of the speciﬁc effects of environmental exposures
on epigenetic features is just in its infancy, and it is
unknown whether these perturbations could impact
leukemogenesis.The Role of Immune Factors in a Cancer of the
Immune System
Infection is a direct cause of viral-induced cancers,
such as human papillomavirus-induced cervical cancerCurr Probl PediatrAdolesc Health Care, October 2016and Merkel cell virus-induced skin cancer. Inﬂamma-
tion from infection is also a risk factor for many
cancers, resulting from the collateral damage of tissue
disorganization, tissue remodeling, and chronic expo-
sure to reactive oxygen species following inﬂamma-
tory processes. Childhood ALL is also a disease of the
immune system, which begs the question can infection
directly stimulate leukemia or stimulate leukemia via
inﬂammatory processes?
Viruses that directly integrate into the genome have
not been reported in childhood ALL. Epidemiological
studies have, however, demonstrated clear effects of
immune factors on leukemogenesis, most overtly in the
form of a consistently observed reduced risk of child-
hood ALL associated with more childhood contacts in
daycare [odds ratio (OR) ¼ 0.77; 95% conﬁdence
interval (95% CI): 0.71─0.84; N ¼ 7399 cases] and
other markers of early exposure to immune stimulus
such as breastfeeding for at least 6 months (OR¼ 0.86,
95% CI: 0.79─0.94), having an older sibling (OR ¼
0.94, 95% CI: 0.88─1.00), or a history of four or more
common infections in the ﬁrst year of life (OR ¼ 0.88,
95% CI: 0.79─0.98).33 Just as regular immune stim-
ulation appears to reduce risk for allergies and asthma,
the same immune exercise can reduce the risk of
leukemia. In the absence of these priming exposures,
children may respond too strongly to the myriad of
infections subsequently encountered in school, result-
ing in a cytokine “storm” and excess cell stimulation,
secondary mutations, and in some cases, leukemia.
This putative pathology is referred to as the “Greaves
hypotheses” after its ﬁrst proponent.34 Other ancillary
data on immune education seem to ﬁt this pattern as
well—normal childhood vaccines, the presence of
older siblings, and breastfeeding were all associated
with reduced risks of childhood leukemia. Population
mixing, in which large numbers of a “new” population
are mixed into a standing community, seems to
transiently increase the risk of leukemia and also ﬁt
with the notion of an infectious stimulation for child-
hood ALL.35 A corollary hypothesis to Greaves' was
suggested by Kinlen who noticed that leukemia space–
time clusters often followed recent population mixing
events, such as the creation of new towns or population
movements during warfare. He proposed that such
mixing facilitated the transmission of a speciﬁc
leukemia-initiating virus which, while plausible, was
not followed up with biological validation as noted
above. More likely, population mixing permits the
transmission of common viruses to populations321
without herd immunity rather than spreading speciﬁc
leukemia-initiating viruses.
Recent studies have noted that the child’s medical
records confuse the infection issue somewhat—ALL
patients visit their general practitioner for infections
in the ﬁrst year of life much more commonly than
children who do not grow up to get leukemia.36,37
This suggests that the damage wrought by fulminant
infections may occur much earlier than previously
thought, and also that children who get leukemia may
respond to infection differently, that is, more strongly
to typical childhood infections. Part of this sensitivity
may be a lack of immunomodulation from suppres-
sive cytokines like IL-10 that tend to be present at
lower levels in newborns who go on to develop
leukemia.38Chemicals as Leukemogens
The ability of a chemical to act as carcinogen was
originally thought to hinge on its capacity as mutagen,
but it is likely that many other more biologically
relevant activities are important in leukemogenesis as
well. Some chemicals exhibit properties that allow
them to target the bone marrow speciﬁcally, due to its
metabolic activity (benzene for an example). Other
chemicals may impact the immune system indirectly,
setting up the individual for aberrant responses to
infection. The role of exogenous factors such as
chemicals, many of which are immunosuppressive, in
this process is unknown and likely to be a major
research ﬁeld in the future. Other activities of chem-
icals are summarized in a recent review of chemicals as
carcinogens.39 Below, we discuss chemical exposures
that may cause leukemia and weigh the evidence for
causal relationships.Environmental Risk Factors for
Childhood Leukemia
Exposure Science in Studies of Childhood
Leukemia Risk
As mentioned earlier, childhood leukemia is the
most common form of pediatric cancer; but, for the
purposes of epidemiological study, it is a rare disease.
As such, the vast majority of epidemiological inves-
tigations into the causes of childhood leukemia are
forced to employ a case–control study design. In322many instances, case–control studies of childhood
leukemia are designed to assess children’s exposure to
disease risk factors retrospectively. That is, a child is
ﬁrst diagnosed with leukemia, then s/he is enrolled in
the case–control study, and only afterwards can in-
vestigators begin to assess the agents to which s/he
has been exposed. This design imposes limitations on
the epidemiologist, as etiologically relevant speci-
mens—biological and environmental—are not neces-
sarily available for collection by the time the child is
under study. As discussed above, childhood leukemia
can be initiated during the prenatal period, but most
cases are not diagnosed until the child is between 2
and 4 years old. This leaves a long time interval
between the ﬁrst windows of susceptibility to leuke-
mogenic agents and the time period when investiga-
tors can start measuring a child’s exposure to those
agents. To overcome these challenges, childhood
leukemia investigators have employed a variety of
strategies to assess children’s exposures to potentially
carcinogenic agents.Using Parent Interviews to Assess Children’s
Exposures to Chemicals
One simple way to circumvent the need for the
collection of biological or environmental samples
during etiologically relevant time periods is to inter-
view participating parents to obtain information about
their child’s history of exposure to speciﬁc agents.
Such interviews can be used to pinpoint historical
exposures during critical windows of a child’s devel-
opment (e.g., the second trimester of pregnancy), they
can be wide-ranging in scope, and they can be
especially effective in assessing parents' conscious
behaviors (e.g., smoking habits, residential pesticide
use, occupational histories). On the other hand,
interview-based exposure assessments have inherent
limitations; they are imprecise measures of chemical
exposure, they provide little information about any of a
child’s exposures that go unrecognized by the parents,
and they are potentially subject to recall and reporting
biases if parents of case and control children remember
or report their children’s exposures in different ways.
In practice, though, reproducibility studies have sug-
gested that, for some of the environmental exposures
that are of interest in childhood leukemia research—
ionizing radiation,40–42 pesticides,43 and smoking27—
there is minimal evidence of differential recall between
cases and controls.Curr Probl PediatrAdolesc Health Care, October 2016
Measuring Chemicals in Settled Dust
Another strategy to obtain information about a
child’s exposure to chemicals during etiologically
relevant time periods is to measure levels of chemicals
in stable environmental matrices. For example, persis-
tent chemicals accumulate on settled dust particles,
which can become trapped deep within a carpet, and
this settled dust acts as a long-term reservoir for these
chemicals.44 With limited exposure to direct sunlight
and microbial action, persistent chemicals, like poly-
chlorinated biphenyls (PCBs), are extremely slow to
degrade on dust particles that settle indoors. As a
result, collecting samples of settled dust from carpets
or other household surfaces and measuring levels of
persistent chemicals in these samples provides an
integrated measure of chemical contamination over a
long period of time.
As part of the California Childhood Leukemia Study, we
have collected multiple dust samples from a large group of
homes at time intervals of several years between sampling
rounds. We found that while there was substantial
variability in chemical levels between sampling rounds,
there was also moderate correlation in the relative ranking
of exposures (i.e., rankings from highest to lowest
exposures) among homes over time.45–47 These ﬁndings
support the hypothesis that chemical levels in dust samples
collected after diagnosis may be informative surrogates forChemicals measured in samples
of settled dust collected from a
child’s home after diagnosis are
useful surrogates for the chemical
exposures s/he received during
etiologically-relevant periods
before and after birth.chemical contamination that was
present in the home during impor-
tant developmental periods of a
child’s life.
Accidental ingestion of settled
dust is an important route of
human exposure to chemicals
along with the consumption of
contaminated food and the inhala-
tion of contaminated air. For exam-
ple, it has been suggested that dust
ingestion is the major route of
exposure to the ﬂame retardant chemicals, polybrominated
diphenyl ethers (PBDEs) in North America48 and positive
relationships have been observed between PBDE levels in
matched samples of dust and serum among U.S.
adults.49,50 Due to their tendency to make hand-to-mouth
contact and their proximity to the ﬂoor, young children are
expected to receive a relatively large proportion of their
total chemical intake via settled dust compared to adults,51
and a positive relationship has been observed between
PBDE levels in matched samples of dust and serum in one
investigation of toddlers from North Carolina.52 Likewise,Curr Probl PediatrAdolesc Health Care, October 2016research from the Center for Integrative Research on
Childhood Leukemia and the Environment also indicates
a relationship between levels of persistent chemicals in
matched samples of settled dust and biospecimens.53,54
Taken together, the observation that chemical levels can be
correlated in matched samples of settled dust and human
serum as well as the observation that chemical levels in
settled dust are relatively stable over time support the use
of chemical levels measured in dust collected after
diagnosis as surrogates for chemical exposures that
children received during etiologically relevant time periods
(before diagnosis).Estimating Ambient Environmental Exposures
Using Geographic Information Systems
An alternative strategy for assessing a child’s history of
environmental exposures is to estimate ambient pollution
using Geographic Information Systems (GIS) and geo-
spatial modeling and to use these estimates of ambient
conditions as surrogates for the child’s total exposure to
chemicals. Many governing bodies record a child’s home
address on the birth certiﬁcate and this information can be
obtained for research purposes contingent on appropriate
ethical review and approval. Exposure models based on
GIS data and geocoded birth addresses could provideuseful information about child-
ren’s exposure to chemicals at
the time of birth and, potentially,
throughout the prenatal period as
well (if participating mothers did
not change residence during
pregnancy). Moreover, complete
residential histories can be
obtained from parents via inter-
view, which allows for a more
comprehensive model of a
child’s historic exposures toambient chemicals. Agricultural pesticide applica-
tion,55,56 trafﬁc-related air pollution,57 and electromag-
netic ﬁelds58 have been estimated using GIS in the
context of epidemiological studies of childhood leuke-
mia. One limitation of using estimates of ambient
pollution as surrogates for total exposures is the inability
to account for chemical exposures that occur indoors.
This is a substantial drawback, because children tend to
spend the vast majority of their time indoors, there are
distinct chemical sources indoors, and chemical expo-
sures tend to be higher indoors than outdoors.59,60323
Measuring Chemicals in Archived
Pre-diagnostic Biospecimens
Perhaps the most straightforward way to obtain pre-
diagnostic biospecimens would be to establish a
prospective birth cohort and follow leukemia incidence
in the participating children into adulthood. However,
as discussed above, this study design is generally
not feasible for childhood leukemia and will generally
be limited by a small number of available cases.
The International Childhood Cancer Cohort Consor-
tium seeks to combine a number of large infant/
child prospective studies (on the order of 100,000Epidemiological studies have
identiﬁed several environmental
risk factors for childhood
leukemia and those ﬁndings
have been conﬁrmed with large
meta-analyses and pooled
analyses that combined data
from thousands of children with
leukemia and healthy controls.participants per study)—
which were originally
designed to examine envi-
ronmental and genetic
determinants of common
childhood diseases—for
pooled analyses of child-
hood leukemia and other
childhood cancers.61
Alternatively, it may be
possible to utilize archived
biospecimens—collected
before diagnosis as part of
routine medical testing—to
measure prenatal chemical exposures.62 For example, in
many countries, blood spots are collected from each
newborn infant by heel-stick for the purposes of genetic
screening. In the State of California, blood spots left over
from genetic screening are archived in a State laboratory
and made available for research contingent upon appro-
priate ethical review and approval. These archived
neonatal blood spots provide a useful resource for
childhood leukemia research, offering insight into the
chemicals to which the developing fetus was exposed
during the prenatal period, including folate,63 cotinine,64
and PBDEs.65 Using current technology for exposure
biology, investigators can characterize prenatal exposure
to thousands of different chemicals with as little as a few
drops of archived neonatal blood. Some important
technical considerations include the potential instability
of chemical analytes during long-term storage, the
possibility of chemical contamination during storage,
and the complex dynamics of newborn metabolite levels
immediately after birth.66 Despite these limitations, the
use of archived pre-diagnostic biospecimens for expo-
sure assessment in epidemiological studies of childhood
leukemia is very promising.324Using these strategies for assessing children’s exposure
to environmental agents, epidemiologists have identiﬁed
several suspected environmental risk factors for childhood
leukemia, including pesticides, parental smoking, paint,
petroleum solvents, trafﬁc emissions, persistent organic
pollutants, and radiation, as summarized in Table 1.Pesticides
Several studies have suggested that home pesticide
exposure before birth and during a child’s early years
may increase the risk of childhood leukemia. Indeed,Curexposure to pesticides is one of the
most frequently investigated chemi-
cal risk factors for childhood leuke-
mia. A causal link between exposure
to pesticides and childhood leukemia
is supported by many studies, includ-
ing the California Childhood Leuke-
mia Study, which demonstrated a
relationship between exposure to
insecticides—as a general class—
and childhood leukemia.67 Existing
studies have generally used inter-
views with parents to assess child-
ren’s exposure to pesticides; as such,no speciﬁc pesticide, or class of pesticides, has been
implicated as the causal agent underlying these
observations.
Pooled Analyses of Home Pesticide Use and
Childhood Leukemia
Investigators from the Childhood Leukemia Interna-
tional Consortium pooled individual parents' responses
to interview questions about children’s exposure to
pesticides from 12 case–control studies.29 Each con-
tributing study used a unique set of questions, often
written in different languages, so exposure data were
harmonized into compatible formats before pooled
analyses could be conducted using multivariable logis-
tic regression. ALL was associated with any pesticide
exposure shortly before conception (OR ¼ 1.39; 95%
CI: 1.25–1.55; N ¼ 2785 cases and 3635 controls),
during pregnancy (OR ¼ 1.43; 95% CI: 1.32–1.54;
N¼ 5055 cases and 7370 controls), and after birth (OR
¼ 1.36; 95% CI: 1.23–1.51; N ¼ 4162 cases and 5179
controls). Corresponding odds ratios for risk of AML
were 1.49 (95% CI: 1.02─2.16, N ¼ 173 cases and
1789 controls), 1.55 (95% CI: 1.21–1.99; N ¼ 344r Probl PediatrAdolesc Health Care, October 2016
TABLE 1. Environmental risk factors for childhood leukemia
Childhood leukemia
risk factor
Exposure measure Level of consensus Subtype
speciﬁcity
Exposure details Odds ratio (95% CI)
Home pesticide use Parental interview Pooled analysis of 12 studies
from CLIC.29
ALL Before conception 1.39 (1.25, 1.55)
ALL During pregnancy 1.43 (1.32, 1.54)
ALL After birth 1.36 (1.23, 1.51)
AML Before conception 1.49 (1.02, 2.16)
AML During pregnancy 1.55 (1.21, 1.99)
AML After birth 1.08 (0.76, 1.53)
Parental occupational
exposure to
pesticides
Parental interview Pooled analysis of 13 studies
from CLIC & meta-analysis
of CLIC þ non-CLIC studies.74
ALL Maternal during
pregnancy
1.01 (0.78, 1.30)
ALL Paternal at conception 1.20 (1.06, 1.38)
T-cell ALL Paternal at conception 1.42 (1.04, 1.94)
ALL after 5y Paternal at conception 1.38 (1.13, 1.67)
AML Maternal during
pregnancy
1.94 (1.19, 3.18)
AML Paternal at conception 0.91 (0.66, 1.24)
Proximity to agricultural
pesticide application
GIS Model Novel ﬁnding.55 ALL Insecticides, moderate,
lifetime
1.5 (0.9, 2.4)
ALL Fumigants, moderate,
lifetime
1.7 (1.0, 3.1)
ALL Organophosphates,
moderate, lifetime
1.6 (1.0, 2.7)
ALL Chlorinated phenols,
moderate, lifetime
2.0 (1.0, 3.8)
ALL Triazines, moderate,
lifetime
1.9 (1.0, 3.7)
Chlorthal, an herbicide Settled dust levels Novel ﬁnding.80 ALL Detected, 1st Tertile vs.
Not Detected
1.49 (0.82, 2.72)
ALL Detected, 2nd Tertile vs.
Not Detected
1.49 (0.83, 2.67)
ALL Detected, 3rd Tertile vs.
Not Detected
1.57 (0.90, 2.73)
Parental smoking Parental interview Pooled analysis of 14 studies
from CLIC & meta-analysis
of CLIC þ non-CLIC studies.83
AML Paternal at any time 1.34 (1.11, 1.62)
AML Maternal during
pregnancy, Latinas
2.08 (1.20, 3.61)
AMMoL Paternal at any time 1.87 (1.08, 3.25)
Home paint use Parental interview Pooled analysis of 8 studies
from CLIC.86
ALL 1–3 months before
conception
1.54 (1.28, 1.85)
ALL During pregnancy 1.14 (1.04, 1.25)
ALL After birth 1.22 (1.07, 1.39)
ALL Professional painter,
during pregnancy
1.66 (1.21, 2.28)
ALL—t(12;21) During pregnancy 1.51 (1.08, 2.11)
Parental occupational
exposure to paint
Parental interview Pooled analysis of 13 studies
from CLIC.89
ALL Paternal at conception 0.93 (0.76, 1.14)
ALL Maternal during
pregnancy
0.81 (0.39, 1.68)
AML Paternal at conception 0.96 (0.65, 1.41)
AML Maternal during
pregnancy
1.31 (0.38, 4.47)
Meta-analysis.88 ALL Maternal during
pregnancy
1.23 (1.02, 1.47)
Parental occupational
exposure to solvents
Parental interview Meta-analysis.88,90 ALL All solvents, maternal
during pregnancy
1.25 (1.09, 1.45)
ALL Petroleum, maternal
during pregnancy
1.42 (1.10, 1.84)
ALL 1.71 (0.91, 3.24)a
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TABLE 1. (Continued )
Childhood leukemia
risk factor
Exposure measure Level of consensus Subtype
speciﬁcity
Exposure details Odds ratio (95% CI)
Benzene, maternal
during pregnancy
Replicated.91 ALL Org. solvents, paternal
at conception
1.48 (1.01, 2.16)
ALL Cl-hydrocarbon, paternal
at conception
2.28 (0.97, 5.37)
Trafﬁc-related air
pollution
GIS model Two independent meta-
analyses.92,93
ALL Trafﬁc density 1.25 (0.92, 1.69)
Any Trafﬁc density 1.53 (1.12, 2.10)
ALL Nitrogen dioxide
estimates
1.21 (1.04, 1.41)
AML Benzene estimates 2.28 (1.09, 4.75)
PAHs Settled dust levels,
vacuum cleaners
Novel ﬁnding.94 ALL Benzo[a]pyrene 1.42 (0.95, 2.12)
ALL Dibenzo[a,h]anthracene 1.98 (1.11, 3.55)
ALL Benzo[k]ﬂuoranthene 1.71 (0.91, 3.22)
ALL Indeno[1,2,3-c,d]pyrene 1.81 (1.04, 3.16)
ALL PAH toxic equivalence 2.35 (1.18, 4.69)
PCBs Settled dust levels Novel ﬁnding.81 ALL Any PCB detected vs.
none detected
1.97 (1.22, 3.17)
ALL Top quartile Σ6PCB vs.
bottom quartile
2.78 (1.41, 5.48)
PBDEs Settled dust levels Novel ﬁnding.95 ALL Top quartile ΣPenta-
BDEs vs. bottom
0.7 (0.4, 1.3)
ALL Top quartile ΣOcta-BDEs
vs. bottom
1.3 (0.7, 2.3)
ALL Top quartile ΣDeca-
BDEs vs. bottom
1.0 (0.6, 1.8)
ALL BDE-196 concentrations 2.1 (1.1, 3.8)
ALL BDE-203 concentrations 2.0 (1.1, 3.6)
ALL BDE-206 concentrations 2.1 (1.1, 3.9)
ALL BDE-207 concentrations 2.0 (1.03, 3.8)
ALL ¼ acute lymphoblastic leukemia; AML ¼ acute myeloblastic leukemia; AMMoL ¼ acute myelomonocytic leukemia; CI ¼ conﬁdence
interval; CLIC ¼ Childhood Leukemia International Consortium; GIS ¼ geographic information systems; PAHs ¼ polycyclic aromatic
hydrocarbons; PCBs ¼ polychlorinated biphenyls; PBDEs ¼ polybrominated diphenyl ethers.
aRelative risk reported.cases and 4666 controls) and 1.08 (95% CI: 0.76–1.53,
N ¼ 198 cases and 2655 controls), respectively.
The Childhood Leukemia International Consortium
investigators29 conﬁrmed the observed association
between home pesticide exposure during pregnancy
and childhood leukemia using meta-analyses as
well. Other investigators have reported similar ﬁndings
in independent meta-analyses,68–70 generally observ-
ing the strongest associations for indoor insecticide use.Pooled Analyses of Parental Occupational
Exposure to Pesticides and Childhood
Leukemia
Given the consistently observed association between
home pesticide use during early childhood and326leukemia risk, a logical extension of this line of
research has been to examine the effect of parental
occupational exposure to pesticides on childhood
leukemia risk. There is evidence that adults exposed
to pesticides at work can track these chemicals back to
their homes on their shoes, clothing, and skin, poten-
tially exposing their families.71,72 Moreover, paternal
exposure to pesticides before conception could result
in germ cell damage, whereas maternal exposure to
pesticides during pregnancy could also expose the
fetus to these chemicals.73 The Childhood Leukemia
International Consortium investigators pooled individ-
ual parents' responses to interview questions about job
histories and the data were harmonized to a compatible
format that characterized parents' pesticide exposures
at work.74 ALL was associated with paternal exposureCurr Probl PediatrAdolesc Health Care, October 2016
to pesticides at work around the time of conception
(OR ¼ 1.20; 95% CI: 1.06─1.38; N ¼ 8169 fathers of
cases and 14,201 fathers of controls), but was not
associated with maternal exposure during pregnancy
(OR ¼ 1.01; 95% CI: 0.78─1.30; N ¼ 8236 case and
14,850 control mothers). In contrast, AML was asso-
ciated with maternal exposure to pesticides at work
during pregnancy (OR ¼ 1.94; 95% CI: 1.19─3.18;
N ¼ 1329 case and 12,141 control mothers), but was
not associated with paternal exposure around the time of
conception (OR ¼ 0.91; 95% CI: 0.66─1.24; N ¼ 1231
case and 11,383 control fathers). The modest associa-
tion between paternal exposure to pesticides around the
time of conception and ALL risk in the offspring was
more evident in children diagnosed at an older age
(5þ years old) and in children with the T-cell ALL
subtype. The Childhood Leukemia International Con-
sortium’s ﬁndings of a signiﬁcant association between
maternal exposure to pesticides during pregnancy and
AML risk in the offspring is consistent with previous
reports.75–77
In a meta-analysis that accompanied the above-
referenced pooled analysis, the Childhood Leukemia
International Consortium investigators74 found a
positive association between maternal occupational
exposures to pesticides during pregnancy and
AML as well as between paternal occupational expo-
sures around conception and T-cell ALL. This
meta-analysis followed a systematic review and it
included studies participating in the Childhood
Leukemia International Consortium as well as non-
participating, independent studies. Other investiga-
tors78,79 have reported similar ﬁndings in independent
meta-analyses, observing an association between pre-
natal maternal exposure to pesticides at work and
childhood leukemia.GIS-Estimated Ambient Pesticide Levels and
Childhood Leukemia
Investigators from the California Childhood Leuke-
mia Study have also evaluated the association between
residential proximity to agricultural pesticide applica-
tions and childhood ALL.55 For the families of 213
ALL cases and 268 matched controls, the authors
linked residential histories together with agricultural
pesticide use reports from the California Department of
Pesticide Regulation, to assess whether living within a
half-mile (0.8 km) of pesticide applications was asso-
ciated with childhood leukemia risk. Elevated ALLCurr Probl PediatrAdolesc Health Care, October 2016risk was associated with lifetime moderate exposure,
but not high exposure, to certain physicochemical
categories of pesticides, including organophosphates,
chlorinated phenols, and triazines, and with pesticides
classiﬁed as insecticides or fumigants.
Exposure to Herbicides and Childhood
Leukemia
Epidemiological studies of childhood leukemia that
use environmental or biological samples are relatively
scarce. In one such study, investigators from the
California Childhood Leukemia Study evaluated the
relationship between childhood ALL and herbicide
concentrations in settled dust as surrogates of herbicide
exposures.80 The herbicide analysis included 269 ALL
cases 0–7 years of age and 333 healthy controls
matched on date of birth, sex, and race/ethnicity.
Dust samples were collected from carpets using a
high-volume small-surface sampler or from partic-
ipant vacuum cleaners. Concentrations of agricultural
or professional herbicides (alachlor, metolachlor,
bromoxynil, bromoxynil octanoate, pebulate, buty-
late, prometryn, simazine, ethalﬂuralin, and pendi-
methalin) and residential herbicides (cyanazine,
triﬂuralin, 2-methyl-4-chlorophenoxyacetic acid,
mecoprop, 2,4-dichlorophenoxyacetic acid, chlor-
thal, and dicamba) were used in logistic regression
adjusting for age, sex, race/ethnicity, household
income, year and season of dust sampling, neighbor-
hood type, and residence type. The risk of childhood
ALL was associated with dust levels of chlorthal;
compared to homes with a measurement below the
analytical limit of detection, odds ratios for the ﬁrst,
second, and third tertiles were 1.49 (95% CI:
0.82─2.72), 1.49 (95% CI: 0.83─2.67), and 1.57
(95% CI: 0.90─2.73), respectively (p value for linear
trend ¼ 0.05). No other herbicides were identiﬁed as
risk factors of childhood ALL. Metayer et al.80
postulated that 2,3,7,8-tetrachlorodibenzo-p-dioxin
—a potent carcinogen and an impurity found in
chlorthal—might be the causal agent underlying the
observed association.
Limitations of Existing Research on Pesticides
and Childhood Leukemia
Previous studies of the relationship between pesticide
exposure and childhood leukemia, including pooled
analyses conducted by the Childhood Leukemia Inter-
national Consortium have utilized interviews to assess
pesticide exposures to children and their parents.327
Unfortunately, this study design has precluded inves-
tigators from identifying speciﬁc chemicals that may
be causal agents underlying the observed associations.
Findings from the California Childhood Leukemia
Study seem to rule out organochlorine pesticides, such
as DDT and chlordane, as the culpable pesticides
underlying the observed association with childhood
leukemia.81Summary of Existing Research on Pesticides
and Childhood Leukemia
Pooled analyses of data from studies around the
world show a relationship between home pesticide
use—especially of insecticides indoors—and the risk
of childhood leukemia, which is conﬁrmed by inde-
pendent systematic reviews and meta-analyses.
Pooled analyses of data from the Childhood Leukemia
International Consortium demonstrate a relationship
between prenatal maternal exposure to pesticides at
work and the risk of childhood AML. Likewise, these
ﬁndings were supported by independent systematic
reviews and meta-analyses. Future studies will con-
tinue to exam relationships between pesticide expo-
sures and the risk of speciﬁc leukemia subtypes and
will also identify the speciﬁc pesticides which act as
causal agents.Parental Smoking
Parental tobacco use is another suspected risk factor for
childhood leukemia that has received a lot of attention
from researchers. Cigarettes contain numerous harmful
constituents and tobacco use is well known to cause a
variety of cancers in adults, including leukemia, via both
direct and secondhand means of exposure. Likewise,
there is evidence that parental cigarette smoking may also
be associated with childhood cancer risk.
Investigators from the California Childhood Leukemia
Study, for example, examined the association between
parental smoking and childhood leukemia among 281
ALL cases, 46 AML cases, and 416 controls matched on
age, sex, maternal race, and Latino ethnicity.82 Maternal
smoking was not associated with an increased risk of
either ALL or AML. Paternal preconception smoking
was signiﬁcantly associated with an increased risk of
AML (OR ¼ 3.84, 95% CI: 1.04─14.17) and marginally
associated with an increased risk of ALL (OR ¼ 1.32,
95% CI: 0.86─2.04).328Pooled Analyses of Parental Cigarette Smoking
and Childhood AML
The Childhood Leukemia International Consortium
pooled individual parents' responses to interview
questions about tobacco use from 14 case–control
studies, representing 1300 AML and 15,000 controls.83
Individual studies ascertained information about paren-
tal cigarette smoking at a number of stages of the
child’s development with varying degrees of speciﬁc-
ity, including maternal smoking during pregnancy and
paternal smoking during the three months before
conception. The ﬁndings from the pooled analyses
strengthened the existing evidence of modest associa-
tions between paternal cigarette smoking at any time
and childhood AML, with dose–response relationships
(po 0.05). Maternal smoking during pregnancy was
associated with an increased risk of AML for Latino
children only.Meta-analyses of Parental Cigarette Smoking
and Childhood ALL
In 2009, a review of studies which evaluated the
association between parental smoking and childhood
leukemia revealed that 6 of 13 studies which had
examined the relationship between paternal smoking
and childhood leukemia reported signiﬁcant positive
associations.84 Subsequently, Liu et al.85 conducted a
meta-analysis, which suggested that childhood ALL
was associated with paternal smoking during precon-
ception (OR ¼ 1.25, 95% CI: 1.08─1.46) during
pregnancy (OR ¼ 1.24, 95% CI: 1.07─1.43), and after
birth (OR ¼ 1.24, 95% CI: 0.96─1.60), with a dose–
response relationships observed between childhood
ALL and paternal smoking before conception or
after birth.Parental Cigarette Smoking and Childhood
Leukemia Subtypes
There is some evidence that the strength of the
association between parental cigarette smoking and
childhood leukemia varies by the cytogenetic subtype
of the tumor. For example, Metayer and colleagues27
reported that children with a history of paternal prenatal
smoking combined with postnatal passive smoking had
a 1.5-fold increased risk of ALL (95% CI: 1.01─2.23),
compared to those without smoking history; but this
joint effect was seen for B-cell precursor ALL with t
(12;21) only (OR ¼ 2.08, 95% CI: 1.04─4.16), not for
high hyperdiploid B-cell ALL. Similarly, theCurr Probl PediatrAdolesc Health Care, October 2016
aforementioned pooled AML analysis conducted by the
Childhood Leukemia International Consortium found
that the highest smoking-related risk was seen for the
myelomonocytic leukemia, a subtype common in
treatment-related AML. Childhood leukemia comprises
many subtypes and these ﬁndings demonstrate that each
subtype may have a distinct set of characteristic risk
factors corresponding to its unique etiology. As such,
studies that evaluate subtype-speciﬁc chemical risk
factors are the most likely to identify true relationships.
Tellingly, when risk factors for each leukemia subtype
are considered separately, higher odds ratios tend to be
revealed.
Limitations of Existing Research on Tobacco
Use and Childhood Leukemia
As was the case for pesticides above, previous
studies of the relationship between parental tobacco
use and childhood leukemia, including pooled analyses
conducted by the Childhood Leukemia International
Consortium, have utilized interviews to characterize
parental smoking histories. This method of exposure
assessment is useful, because it allows investigators to
examine the effect of parental smoking at critical
windows of a child’s development and because it
enables investigators to untangle the separate effects
of cigarette smoking done by the mother, father, or
other family members. Moreover, in contrast to other
environmental exposures that are of interest to leuke-
mia researchers, parents are conscious of the number of
cigarettes they tend to smoke each day and they can
help quantify their own exposures to tobacco. How-
ever, recall and reporting biases are still concerns, as
parents (especially parents of children with leukemia)
may not accurately remember or may not feel comfort-
able discussing their past tobacco use history during
the interview. The lack of an observed association
between maternal smoking during pregnancy and
childhood leukemia may be related to this potential
for bias when using interview data to assess exposure.
Alternatively, the lack of an observed association may
also be the result of smoking-induced adverse birth
outcomes (e.g., fetal loss, still birth) that preclude the
subsequent development of childhood leukemia,
thereby biasing epidemiological ﬁndings.
Summary of Existing Research on Tobacco Use
and Childhood Leukemia
Pooled analyses of data from studies around the
world show a relationship between paternal smokingCurr Probl PediatrAdolesc Health Care, October 2016before conception and AML risk. Likewise, these
ﬁndings were supported by an independent systematic
review and meta-analysis. Future studies will provide
an increased focus on the role of prenatal maternal
smoking on leukemia risk in Latino children and will
pool data from the Childhood Leukemia International
Consortium for an analysis of smoking-related ALL
risk.
Chemicals Found in Paints, Petroleum Solvents,
and Traffic Emissions
A collection of studies have investigated the associ-
ations between childhood leukemia and a loosely-
related group of environmental exposures including
paint, petroleum solvents, and vehicle trafﬁc. These
general exposure categories share characteristic chem-
ical signatures, including the leukemogenic agent,
benzene.
Investigators from the California Childhood Leuke-
mia Study examined the association between child-
hood leukemia and the use of paint or petroleum
solvents in the home before birth and in early child-
hood. The analysis included 550 ALL cases, 100 AML
cases, and one or two controls per case individually
matched for sex, age, Latino ethnicity, and race.
Conditional logistic regression techniques were used
to adjust for income. Home paint exposure was
associated with ALL risk (OR¼1.65; 95% CI:
1.26─2.15). The association was restricted to ALL
with t(12;21) (OR ¼ 4.16, 95% CI: 1.66─10.4). Home
use of petroleum solvents was associated with an
increased risk for AML (OR ¼ 2.54, 95% CI:
1.19─5.42) but not ALL.
Pooled Analyses of Home Exposure to Paint
and Childhood Leukemia
The Childhood Leukemia International Consortium
pooled individual responses to questions about home
paint exposures from eight case–control studies.86 Data
were harmonized to account for inter-study differences
in reported paint types, time periods of exposure, and
leukemia subtypes and a compatible format was used
in logistic regression. ALL risk was associated with
home paint exposure in the 1–3 months before
conception (OR ¼ 1.54; 95% CI: 1.28─1.85; N ¼
3002 cases and 3836 controls), during pregnancy (OR
¼ 1.14; 95% CI: 1.04─1.25; N ¼ 4382 cases and 5747
controls), and after birth (OR ¼ 1.22; 95% CI:
1.07─1.39; N ¼ 1962 cases and 2973 controls). The329
risk was greater if someone other than the parents did
the painting, for example, a professional painter, which
is indirect evidence of a dose–response relationship.
The paint–leukemia association was stronger for ALL
with t(12;21) than for other cytogenetic subtypes of
leukemia.
Meta-analyses of Parental Occupational
Exposures to Paint, Solvents, Vehicle Exhaust,
and Childhood Leukemia
As an extension of the research that has identiﬁed
an association between exposure to paint in the home
and childhood leukemia, meta-analyses have demon-
strated associations between childhood leukemia
risk and parental exposures in related occupational
settings.
For example, a meta-analysis summarizing the exist-
ing literature on parental occupational exposures and
childhood cancer found that relationships between
childhood leukemia and paternal exposure to paints,
solvents (e.g., benzene and trichloroethylene), and
employment in motor vehicle-related occupations were
among the strongest of the more than 1000 occupa-
tion–childhood cancer combinations that were eval-
uated.87 The studies that comprised this meta-analysis
had several limitations related to the quality of the
exposure assessment including the small numbers of
exposed cases studied, the likelihood of false positives
due to multiple comparisons, and possibility of pub-
lication bias. Despite these limitations, this meta-
analysis provides evidence that when parents are
exposed to certain chemicals at work, the effects are
harmful to their offspring.
Another meta-analysis summarized ﬁndings from 28
case–control studies and one cohort study that inves-
tigated the relationship between maternal occupational
exposures and childhood leukemia in the offspring
using 16,695 participating cases and 1,472,786 con-
trols.88 ALL risk was associated with maternal paint
exposures at work during pregnancy (OR ¼ 1.23, 95%
CI: 1.02─1.47), with maternal solvent exposures at
work during pregnancy (OR ¼ 1.25, 95% CI:
1.09─1.45), and with maternal petroleum exposure at
work during pregnancy (OR ¼ 1.42, 95% CI:
1.10─1.84). No publication bias was found in this
meta-analysis and consistent results were observed for
subgroup and sensitivity analyses. However, an anal-
ysis of parental occupational paint exposures pooled
from 13 case–controls studies revealed no increased
risk for childhood ALL or AML.89330Carlos-Wallace et al.90 conducted meta-analyses to
evaluate the risk of childhood leukemia associated with
parental occupational exposure to benzene and solvents,
as well as household use of products containing benzene
and solvents. Maternal occupational exposure to ben-
zene was associated with increased risk of childhood
leukemia, yielding a summary relative risk of 1.71 (95%
CI: 0.91─3.24). Use of household products containing
benzene, aromatic hydrocarbons, solvents, or petro-
leum, was also associated with childhood leukemia
risk, with a summary relative risk of 1.67 (95% CI:
1.01─2.78). The above associations were stronger for
AML than for ALL and strongest for women who were
exposed during pregnancy.
The California Childhood Leukemia Study examined
the relationship between occupational exposure to
organic solvents and the risk of childhood leukemia.91
Occupational histories were obtained via interview
using 19 task-based job modules from parents of
children with ALL (N ¼ 670), children with AML
(N ¼ 104), and healthy control children (N ¼ 1021).
Logistic regressions were used to estimate odds ratios
adjusted for socio-demographic factors. Among chil-
dren with non-Latino fathers, none of the exposures
evaluated were associated with risks of ALL and AML.
In contrast, exposure to any organic solvents in Latino
fathers was associated with an increased risk of child-
hood ALL (OR ¼ 1.48, 95% CI: 1.01─2.16); in
multivariable analyses and the odds ratio for exposure
to chlorinated hydrocarbons, in particular, was elevated
(OR ¼ 2.28, 95% CI: 0.97─5.37), whereas risk
estimates for other exposures—aromatic hydrocarbons,
glycol ethers, and other hydrocarbon mixtures—were
close to one. One common industrial chlorinated hydro-
carbon, which might be the causal agent underlying the
observed association, is trichloroethylene (TCE). As
with other analyses that rely on interview-derived
exposure data, the speciﬁc chlorinated hydrocarbon or
mixture of chlorinated hydrocarbons responsible for the
associations observed in these studies is not known. A
large majority of mothers were not exposed to chem-
icals at work, and no associations were reported for risk
of childhood ALL and AML.Traffic-Related Air Pollution and Childhood
Leukemia
Three recent meta-analyses independently demon-
strated an association between childhood leukemia and
postnatal trafﬁc exposure.90,92,93 Boothe et al.92Curr Probl PediatrAdolesc Health Care, October 2016
combined ﬁndings from seven studies to estimate that
childhood leukemia was positively associated with
postnatal trafﬁc density near the residence (OR ¼
1.53, 95% CI: 1.12─2.10). There was no association
between childhood leukemia and prenatal trafﬁc
exposures.
Filippini et al.93 combined 6 ecologic and 20 case–
control studies that had assessed home exposure to
trafﬁc-related pollution by estimating trafﬁc density in
the neighboring roads, by estimating the vicinity to gas
stations, or by modeling ambient nitrogen dioxide and
benzene concentrations with GIS. Among high-quality
studies that used trafﬁc density to assign exposure, no
signiﬁcant increase in childhood leukemia risk was
observed, even in the highest exposure category (OR¼
1.07, 95% CI: 0.93─1.24). Among studies that used
NO2 estimates as the measure of exposure, there was a
marginally signiﬁcant association with childhood leu-
kemia (OR ¼ 1.21, 95% CI: 0.97─1.52), which was
stronger for ALL (OR ¼ 1.21, 95% CI: 1.04─1.41)
than for AML (OR ¼ 1.06, 95% CI: 0.51─2.21).
Among studies that used benzene estimates as the
measure of exposure, there was a stronger association
with AML (OR ¼ 2.28, 95% CI: 1.09─4.75) than ALL
(OR ¼ 1.09, 95% CI: 0.67─1.77). Observed associa-
tions between childhood leukemia and exposure to
trafﬁc pollution were generally stronger for exposures
in the postnatal period compared to the prenatal period.
Carlos-Wallace et al.90 conducted meta-analyses to
evaluate the risk of childhood leukemia associated with
trafﬁc density and trafﬁc-related air pollution. Both
measures of trafﬁc were associated with childhood
leukemia; the summary relative risk was 1.48 (95% CI:
1.10─1.99). The relationship was stronger for AML
than for ALL and stronger in studies that involved
detailed models of trafﬁc pollution than in those that
estimated trafﬁc density.
The ﬁndings from these three meta-analyses support
a link between ambient exposure to trafﬁc pollution
and childhood leukemia risk, particularly due to
benzene.
Benzene as the Potential Causal Agent
Once again, most of the studies that have evaluated
the risk of childhood leukemia associated with paint,
petroleum solvents, or trafﬁc density are based on
parent interviews. As such, it is challenging to identify
the speciﬁc causal agent underlying the observed
associations in these existing studies. Benzene is one
potential culprit as it is a well-known leukemogen thatCurr Probl PediatrAdolesc Health Care, October 2016is present in oil-based paints, petroleum solvents used
in occupational and residential settings (e.g., in paint
thinner), and vehicle exhaust. However, given that
childhood leukemia subtype analyses have yielded
disparate results depending on the speciﬁc exposure
measure that was used in the meta/pooled analysis, it is
also possible that this loose grouping of chemical
exposures actually comprises several distinct chemical
risk factors for leukemia. For example, in addition to
benzene, other chemicals, such as 1,3-butadiane,
styrene, xylene, and polycyclic aromatic hydrocarbons
(PAHs) might also play a role in some of these
observed relationships. The recent development of a
mouse model for childhood leukemia will enable
investigators to evaluate the role of speciﬁc chemical
risk factors in the etiology of childhood leukemia.
Summary of Existing Research on Paint,
Solvents, Traffic and Childhood Leukemia
Pooled analyses of data from studies around the
world show a relationship between home exposure to
paint and ALL risk. These ﬁndings were indirectly
supported by a variety of systematic reviews and meta-
analyses, which showed evidence of relationships
between childhood leukemia and exposure to petro-
leum solvents (at home and at the mother’s work) and
trafﬁc (as measured by surrounding trafﬁc density and
modeled concentrations of trafﬁc-related air pollu-
tants). Several possible chemical risk factors may
explain the observed association, including the well-
known leukemogen, benzene.
Persistent Organic Pollutants
Epidemiological studies of childhood leukemia that
use environmental or biological samples are relatively
scarce. A series of analyses conducted as part of the
California Childhood Leukemia Study have evaluated
the relationship between childhood ALL and chemical
concentrations in settled dust collected from participat-
ing homes as surrogates for chemical exposures.
Polycyclic Aromatic Hydrocarbons (PAHs) and
Childhood Leukemia
The California Childhood Leukemia Study evaluated
the relationship between childhood ALL and PAH
concentrations in settled dust.94 As part of this
population-based case–control study, dust samples
were collected from 251 ALL cases and 306 birth-
certiﬁcate controls using a high-volume small-surface331
sampler (N ¼ 185 cases, 212 controls) or directly from
participants' household vacuum cleaner bags (N ¼ 66
cases, 94 controls). Logistic regression was used to
evaluate the relationship between ALL risk and log-
transformed concentrations of 9 individual PAHs, the
summed PAHs, and the summed PAHs weighted by
their carcinogenic potency (the toxic equivalence)
while adjusting for demographic characteristics and
duration between diagnosis/reference date and dust
collection. Among participants with dust samples
collected by high-volume small-surface sampler, risk
of ALL was not associated with increasing concen-
tration of any PAHs. However, among participants
with dust samples collected by participants' vacuum
cleaners, a positive association was observed between
ALL risk and increasing concentrations of benzo[a]
pyrene (OR ¼ 1.42, 95% CI: 0.95─2.12), dibenzo[a,h]
anthracene (OR ¼ 1.98, 95% CI: 1.11─3.55), benzo[k]
ﬂuoranthene (OR ¼ 1.71, 95% CI: 0.91─3.22), indeno
[1,2,3-cd]pyrene (OR ¼ 1.81, 95% CI: 1.04─3.16),
and the toxic equivalents (OR ¼ 2.35, 95% CI:
1.18─4.69). The observed association between ALL
risk and PAH concentrations among participants with
dust collected by vacuum suggests that PAH exposure
may increase the risk of childhood ALL; however,
understanding the reasons for the different results by
sample type requires further scrutiny.
PAHs are byproducts of incomplete combustion that
are found at high concentrations in cigarette smoke and
vehicle exhaust. PAHs, especially dibenzo[a,h]anthra-
cene, are potent human carcinogens. As such, it is
possible that one PAH or a combination of PAHs may
be the causal agent(s) responsible for the observed
associations between parental smoking and childhood
leukemia or between trafﬁc density and childhood
leukemia.Polychlorinated Biphenyls (PCBs) and
Childhood Leukemia
The California Childhood Leukemia Study has also
evaluated the relationship between childhood ALL and
levels of six PCBs—industrial chemicals that are
probable human carcinogens and immune system
disruptors—in settled dust.81 The PCB analysis
included 184 ALL cases 0–7 years of age and 212
birth certiﬁcate controls matched to cases by birth date,
sex, race, and Latino ethnicity. Dust samples were
collected from the room where the child spent the most
time using the high-volume small-surface sampler. In332homes where any PCB was detected in the dust, there
was a 2-fold increased risk of ALL (OR ¼ 1.97, 95%
CI: 1.22─3.17). When considering the sum of the six
PCBs analytes, compared to those in the lowest
quartile of Σ6PCBs, the highest quartile was associated
with about a 3-fold risk of ALL (OR ¼ 2.78, 95% CI:
1.41─5.48). The risk of ALL was positively associated
with increasing concentrations of PCB congeners 118,
138, and 153 in dust. The associations with PCBs were
stronger among non-Latino whites than among Latinos
despite the presence of a similar distribution of PCB
levels among controls in each racial/ethnic groups.Polybrominated Diphenyl Ethers (PBDEs) and
Childhood Leukemia
Along the same lines, the California Childhood
Leukemia Study evaluated the relationship between
childhood ALL and levels of PBDEs—chemical ﬂame
retardants—in settled dust.95 PBDEs are structural
analogs to PCBs that also cause immune system
perturbations. The PBDE analysis included 167 ALL
cases 0–7 years of age and 214 birth certiﬁcate controls
matched on date of birth, sex, and race/ethnicity. Dust
samples were collected from carpets in the room where
the child spent the most time while awake using a high-
volume small-surface sampler or by sampling from
participants' household vacuum cleaners. Concentra-
tions of 14 PBDE congeners were measured including
constituents of the Penta- (28, 47, 99, 100, 153, 154),
Octa- (183, 196, 197, 203), and Deca-BDEs commer-
cial mixtures (206–209). Odds ratios were calculated
using logistic regression, adjusting for demographics,
income, year of dust collection, and sampling method.
Comparing the highest to lowest quartile showed no
association with ALL for summed Penta- (OR ¼ 0.7,
95% CI: 0.4─1.3), Octa- (OR ¼ 1.3, 95% CI: 0.7─2.3),
or Deca-BDEs (OR ¼ 1.0, 95% CI: 0.6─1.8). Compar-
ing homes in the highest tertile to those below the
analytical limit of detection, revealed a signiﬁcant
positive association with ALL risk for BDE-196 (OR
¼ 2.1, 95% CI: 1.1─3.8), BDE-203 (OR ¼ 2.0, 95%
CI: 1.1─3.6), BDE-206 (OR ¼ 2.1; 95% CI: 1.1─3.9),
and BDE-207 (OR ¼ 2.0, 95% CI: 1.03─3.8).
Interestingly, the signiﬁcant associations with ALL
risk observed in this analysis were for minor PBDE
congeners that are found in dust at relatively low
concentrations; whereas the most abundant PBDE
congeners (e.g., BDEs 47, 99, and 209) were not
associated with ALL risk. These low-concentrationCurr Probl PediatrAdolesc Health Care, October 2016
PBDE congeners were measured with less analytical
precision than their more common analogs, because the
measured values were relatively close to the analytical
limit of detection. In other words, the low-level PBDE
congeners that were associated with ALL risk in this
analysis were the ones measured with the least
precision and, therefore, the ones with the greatest
potential for a spurious ﬁnding. Still, there may be a
plausible biological mechanism to explain the incon-
sistency of the risk estimates between PBDE conge-
ners, as toxic and carcinogenic effects are expected to
differ by congener.48,96 The fact that PCBs and PBDEs
have a similar chemical structure lends credence to the
hypothesis that these chemicals may be acting via the
same mechanism of action, for example, immune
dysregulation.
Strengths of Existing Research on Persistent
Organic Pollutants and Childhood Leukemia
Unlike much of the research described in this section,
one strength of the existing research on persistent
organic pollutants and childhood leukemia is the use of
objective environmental measurements to assess chem-
ical exposures, rather than interviews. Not only does
this reduce the likelihood of recall bias, but it also
allows investigators to identify speciﬁc chemicals as
causal agents in the etiology of leukemia. Recognizing
causal agents can be the ﬁrst step in planning a
successful intervention that will reduce future inci-
dence of leukemia.
Limitations of Existing Research on Persistent
Organic Pollutants and Childhood Leukemia
The relative stability of persistent organic pollutants
in settled dust allows for exposure measurements that
have limited temporal variability. This stability is a
beneﬁt of the sampling technique, because the result-
ing measurements represent long-term average levels
of chemical contamination, which can be useful
when trying to estimate past chemical exposures.
However, this stability also obscures short-term
ﬂuctuations in chemical levels that might be important
to investigators who want to identify critical windows
of a child’s development when chemical exposures
are especially harmful. That is, measuring chemical
levels in settled dust will not enable a researcher
to distinguish the leukemogenic effect of prenatal vs.
postnatal chemical exposures, for example.Curr Probl PediatrAdolesc Health Care, October 2016Moreover, children are exposed to chemicals through
several other pathways in addition to the ingestion of
contaminated settled dust. In particular, the ingestion
of settled dust plays a relatively minor role in child-
ren’s exposure to PCBs compared to the ingestion of
PCB-contaminated food. This is owing to the bioaccu-
mulative nature of PCBs and the fact that they have
been banned from production in the U.S. for several
decades. Indeed, it is a testament to the persistence of
these hazardous chemicals that they can still be so
readily measured inside homes. In these analyses, the
design of the California Childhood Leukemia Study
did not account for chemical exposures received via
the inhalation of contaminated air, the ingestion of
contaminated food, or any other pathways. As such,
the dust measurements are limited surrogates for total
chemical exposure.
To date, the California Childhood Leukemia Study has
only utilized dust samples to identify risk factors for
ALL, the most common leukemia subtype. There is an
insufﬁcient number participants with dust samples avail-
able to analyze the risk of AML or to stratify by
cytogenetic subtype.
Also of some concern is the fact that the subset of
California Childhood Leukemia Study participants
who were eligible for and consented to dust sampling
had higher socioeconomic status than the full Califor-
nia Childhood Leukemia Study population and its
underlying source population, the State of California.
As such, the ﬁndings from these studies may not be
representative of the general population. Fortunately,
data from the California Childhood Leukemia Study
indicates that both the case families and the control
families participating in dust sampling had elevated
socioeconomic status, which limits the risk of differ-
ential selection bias.
Perhaps the most important limitation of these
studies is that they have not been substantiated by
independent investigators. Whereas many members of
Childhood Leukemia International Consortium and
other studies have collected interview data about
pesticides, smoking, and paint; very few have meas-
ured chemicals in environmental samples. As such,
there are no meta-analyses or pooled analyses pub-
lished showing the risk of ALL associated with
exposure to persistent organic pollutants, as there
have been previously for the other, more well-studied,
ALL risk factors that were discussed above.333
Summary of Existing Research on Persistent
Organic Pollutants and Childhood Leukemia
Three novel ﬁndings from the California Childhood
Leukemia Study suggest that home exposures to
persistent organic pollutants, such as PAHs, PCBs,
and PBDEs, are associated with an increased risk of
ALL. Future studies should attempt to interrogate these
associations to replicate or refute their veracity.Radiation
In utero exposure to low-dose radiation delivered
from medical x-rays is one of the few widely-
recognized risk factors for childhood leukemia.97
While the prevalence of fetal exposure to x-rays in
utero has decreased markedly following radiation
protection standards, the use of medical imaging
procedures, including computerized tomography (CT)
scans,98 has increased drastically during the past 30
years. In fact, CT scans are now the largest medical
sources of radiation in economically developed coun-
tries.99 In addition, CT scans deliver an effective dose
of radiation that is up to several hundred times stronger
than conventional x-rays (depending on the target
organ), which has led to major increases in the per
capita radiation dose from medical sources (up 600%
in the US since 1980).99 The carcinogenic effects of
CT scans have not been established, but exposures to
children are especially concerning because they are
more sensitive to radiation-induced cell damage.97
Findings on children’s postnatal exposure to low-
dose medical radiation and the risk of childhood
leukemia are inconsistent, with modest positive asso-
ciations reported in some studies, but not all.97,99 Risk
prediction models have anticipated increased risks of
childhood leukemia following CT scans, but these
models were criticized for extrapolating from the
effects of much higher levels of radiation that were
observed in the Life Span Study of atomic-bomb
survivors.100–102 Only one case–control study to date
has published results on self-reported history of CT
scans showing no increased risk of childhood ALL,
based on small numbers of exposed children.103
Recent cohort studies with access to medical data in
Europe,101,104–106 Australia,107 and the US,102 have
reported small to moderate increases in the risk of
leukemia in children exposed to CT scans; ﬁndings,
however, were based on small number of excess cases
ranging from 6 to 74. Pearce et al.106 conducted a
retrospective cohort study of 178,604 UK children334and young adults with CT scans from 1985 to 2002.
Patients were followed up through 2008 and linked
with 74 leukemia diagnoses and 135 brain cancer
diagnoses. A cumulative dose of 50 milligray was
estimated to triple the risk of childhood leukemia
within 10 years of the ﬁrst CT scan; likewise, a
cumulative dose of 60 milligray tripled the risk of
brain cancer.106 The main criticism of the study was
the lack of an unexposed control group. Other cohort
studies are underway108 including a pooled European
study (EPI-CT)104 of about one million subjects (age
0–21 years). Although the number of excess child-
hood leukemia cases is still likely to be low (estimated
to be approximately 60–100), this study will obtain
more precise exposure information than previously
possible, including individual doses of radiation for
each organ.
Confounding by indication (reverse causation) is also
a concern in studies of the relationship between medical
radiation and childhood leukemia. In a French cohort
study, the analyses accounting for child’s cancer-
predisposing factors (mostly rare genetic conditions in
less than 2% of children) showed a modest impact on
the risk of childhood leukemia associated with CT
scans.109 This was consistent with a case–control study
of prenatal x-rays showing an overall 13% reduction in
relative risk of childhood cancers, after adjusting for
maternal illnesses during pregnancy.110 Others have
argued that cancer-predisposing conditions may instead
act as effect modiﬁers.111–113 Overall, despite methodo-
logical challenges, epidemiologic studies so far mostly
support an association between postnatal exposure to
CT scans and childhood leukemia, while results for
lower dose x-rays are less consistent.
Pooled analyses reported that exposure to high levels
of extremely low-frequency-electromagnetic ﬁelds
over 0.3 or 0.4 mT is associated with an increased risk
of childhood leukemia,114,115 which was the basis to
classify extremely low-frequency-electromagnetic
ﬁelds as possibly carcinogenic to humans (Group
2B).116 Methodological issues including possible con-
founding, selection bias, and measurement errors have
been put forward as an alternate explanation for the
observed association, and animal studies are ongoing
to identify possible biological mechanisms.117,118 If
the association between extremely low-frequency-
electromagnetic ﬁelds and childhood leukemia is
causal, the overall population attributable risk has
been estimated to be 1.9% (1–4% depending on the
countries).117,118Curr Probl PediatrAdolesc Health Care, October 2016
Future Steps in Identifying Environmental
Causes of Childhood Leukemia
A multitude of studies on the environmental causes of
childhood leukemia, including those conducted by our
research team and others that are described above, have
led to progress in identifying the etiological roles of
environmental exposures in childhood leukemia. How-
ever, much work remains to be done. As discussed,
several of the observed associations between chemical
exposures and childhood leukemia are derived from
interview data, an approach which can limit an inves-
tigator’s ability to identify speciﬁc chemical risk factors
for childhood leukemia. As such one goal of future
research will be to understand which speciﬁc causal
agents underlie previously observed associations. For
example, in collaboration with the National Cancer
Institute, the California Childhood Leukemia Study is
conducting a study to measure glyophosate in partic-
ipating homes. This study will follow-up on a previ-
ously observed association between reported residential
herbicide use and childhood ALL. The California
Childhood Leukemia Study has observed associationsDiet quality is a comprehensive
measure of nutritional status,
and healthy maternal diet at the
time of conception and during
pregnancy is linked to a reduced
risk of leukemia in the offspring.between childhood leukemia risk
and levels of certain PCBs,
PBDEs, PAHs, and herbicides
in settled dust. These unique
ﬁndings need to be conﬁrmed
in independent studies, prefera-
bly in ones that use a distinct
method for assessing children’s
exposure to chemicals.
As an alternative approach for
identifying the causal agents in
childhood leukemia, the Center for Integrative Research
on Childhood Leukemia and the Environment will
employ a mouse model of ALL with t(12;21) to test
the carcinogenic potential of a variety of chemicals,
including, for example, compounds that comprise the
broadly-deﬁned groups of pesticides, solvents, or trafﬁc
pollutants. The mouse model will also be helpful in
identifying mechanisms of action for the chemical risk
factors of childhood leukemia. In fact, this is a central
goal of the Center, as immunological factors and
epigenetics will both be interrogated as possible cancer
mechanisms. Moreover, state-of-the-science untargeted
analytical approaches will allow investigators to identify
novel chemical risk factors for childhood leukemia, byCurr Probl PediatrAdolesc Health Care, October 2016examining relationships between exposure and disease
that have not been considered, to date.Dietary Risk Factors for Childhood
Leukemia
Introduction
Diet has been linked to several cancers in adults and
children.119 These observations may be explained by
various biological mechanisms such as exposure to
dietary mutagens, mutagenesis due to nutrient deﬁ-
ciencies, and intake of micronutrients and other dietary
components that may protect against the development
of cancer by supporting cellular integrity, reducing
inﬂammation and improving immune response.120–122
A growing body of research also suggests that the
inﬂuence of particular nutrients on epigenetic proc-
esses may contribute to carcinogenesis.123
The role of the intrauterine environment is crucial in
determining risk of disease later in life, and the
“developmental origins of health and disease” hypoth-esis posits that nutritional and
environmental exposures in
utero permanently alter gene
expression and the physical
development of the fetus
through a process called “pro-
gramming.”124,125 This hypoth-
esis is likely central to the
development of childhood leu-
kemia, as well. Indeed, mater-
nal nutrition during pregnancymay be related to both the occurrence of primary and
secondary oncogenic events that lead to leukemia in
the offspring. Subsequently, a child’s diet during the
early years of life is likely to also play an important
role in leukemogenesis. Breastfeeding has been con-
sistently found to reduce leukemia risk in children, via
intake of essential nutrients not readily available in
newborns and due to the resulting beneﬁcial effects of
immune system priming. In contrast, the impact of diet
—both the mother’s and the child’s—on childhood
leukemia has been less studied.
Here we provide an overview of the current knowl-
edge about the associations between diet and childhood
leukemia.335
Reduced risks of childhood
leukemia are associated with
adequate folate before
conception and early in
pregnancy, breastfeeding,
and early exposure to routine
childhood infections.Maternal Diet
Epidemiologic studies exam-
ining the relationship between
maternal diet during pregnancy
and the risk of childhood leu-
kemia, have been mostly con-
ducted in developed countries.
Exposures of interest varied to
include food groups (e.g., fruits,
vegetables, proteins), micronu-
trients from dietary and supplement sources (e.g.,
folate and vitamins), food sources of topoisomerase
II inhibitors (known risk factors for treatment-related
leukemia), consumption of coffee, tea, and alcohol,
and holistic measures of a healthy diet.Food Groups
Fruits and vegetables contain a variety of vitamins and
minerals that have anti-cancer, anti-proliferative, and anti-
inﬂammatory effects,123 and the consumption of fruits
and vegetables has been associated with a reduced risk of
various types of cancer.119 Some food groups, in
particular fruits and vegetables, have been associated
with childhood leukemia risk in several studies. Research
has found statistically signiﬁcant negative associations
between maternal consumption of fruits and vegetables
and risk of childhood ALL,126–128 and one study found
signiﬁcant or near-signiﬁcant inverse linear trends
between the risk of infant leukemia and maternal con-
sumption of fresh fruits and vegetables, especially for
speciﬁc ALL subtypes.129 Negative associations have
also been observed for childhood leukemia and maternal
consumption of other food groups, speciﬁcally protein
sources such as ﬁsh and seafood128 as well as beans and
beef.126,127 One study demonstrated an increased risk of
ALL with increased maternal consumption of meat or
meat products and sugars or sirups.128Folate and Other One-Carbon Metabolism
Nutrients
The one-carbon metabolism cycle is critical for the
synthesis of DNA and RNA, the conversion of
homocysteine to methionine, and the formation of
s-adenosylmethionine (SAM), the primary methyl
donor for DNA, RNA, proteins, and lipids.130 Folate
and other B vitamins are important cofactors in the
one-carbon metabolism cycle,130 and maternal folic
acid supplementation during pregnancy has been336 Curr Probldemonstrated to inﬂuence DNA
methylation in children.131
Maternal folic acid supplemen-
tation also protects against some
childhood diseases, such as neu-
ral tube defects.132 High folate
intake has been associated with
reduced risk of breast133 and
colorectal134 cancer and
increased risk of prostate can-
cer135 among adults, whereasmeta-analyses have indicated no effect of folic acid
supplementation on adult cancer incidence.135–137
Maternal intake of folate and other nutrients involved
in one-carbon metabolism may inﬂuence childhood
leukemia risk due to the importance of these nutrients
for DNA synthesis and repair, chromosomal integrity,
and epigenetic processes that determine gene expres-
sion and inﬂuence cancer risk, including histone
modiﬁcation, levels of non-coding RNAs, and DNA
methylation.123,130
Practices of prenatal folic acid supplementation have
varied substantially across countries and over time, and
individual epidemiologic studies that have evaluated
the relationship between maternal folate intake through
supplements and the risk of childhood ALL have
yielded mixed ﬁndings. However, a recent Childhood
Leukemia International Consortium analysis, the larg-
est to date, pooled original interview data from 12
studies (representing 6963 ALL, 585 AML, and
11,635 healthy controls) to observe that folic acid
supplementation was protective against childhood
leukemia.138 Folic acid taken before conception or
during pregnancy—with or without intake of other
vitamins—was associated with a reduced risk of
childhood ALL (OR ¼ 0.80, 95% CI: 0.71─0.89)
and AML (OR ¼ 0.68, 95% CI: 0.48─0.96), after
adjustment for study center.138 Interestingly, the
reduced risks were seen only among women with
low and medium education levels—a surrogate marker
for low socio-demographic status and possibly for a
low-quality (low-folate) diets—suggesting that women
who enter the peri-conception period with inadequate
folate/vitamin levels would beneﬁt the most from
prenatal folate and vitamin supplementation.
Only a small number of studies, however, have
examined the role of folate intake from food or the
role of any other nutrients involved in the one-carbon
metabolism cycle in the development of childhood
leukemia. In addition, there has been only limitedPediatrAdolesc Health Care, October 2016
consideration of the role of maternal diet on risk of
AML. A case–control study in Australia found some
evidence that higher dietary intakes of folate and B12
from food in the last 6 months of pregnancy were
associated with a decreased risk of ALL, whereas
higher dietary intakes of vitamin B6 were unexpectedly
associated with an increased risk of ALL.139 Previous
analyses from a subset of the California Childhood
Leukemia Study population examined the total intake
of folate, vitamin B6 or vitamin B12 from both diet and
supplements, and found no associations with
ALL.126,127,140 However, in a recent and expanded
California Childhood Leukemia Study analysis (681
ALL cases, 103 AML cases, and 1076 controls) that
employed principal components analysis to account for
the high correlations between nutrients, higher mater-
nal intake of one-carbon metabolism nutrients from
food and supplements was associated with a reduced
risk of ALL (OR ¼ 0.91, 95% CI: 0.84─0.99) and
possibly AML (OR ¼ 0.83, 95% CI: 0.66─1.04).141
The association of ALL with nutrient intake exclu-
sively from food (excluding supplements) was similar
to the association of total nutrient intake from food and
supplements, both in the study population overall and
within racial/ethnic groups. However, high intake of B
vitamins from supplements (versus none) was associ-
ated with a statistically signiﬁcant reduced risk of ALL
in children of Latinas (OR¼ 0.36 95% CI: 0.17─0.74),
but not in children of non-Latina white women (OR ¼
0.76, 95% CI: 0.50─1.16) or Asian women (OR ¼
1.51, 95% CI: 0.47─4.89).141 Racial/ethnic differences
in nutrient intake and in genetic polymorphisms in the
one-carbon (folate) pathway may partly explain the
observed difference in leukemia risk.
In a biomarker analysis conducted as part of the
California Childhood Leukemia Study, folate concen-
tration measured in neonatal blood samples were
similar between children with leukemia (313 ALL
cases and 44 AML cases) and 405 controls, suggesting
that folate levels at the end of pregnancy did not affect
leukemia risk.63 The study was conducted in California
where most pregnant women used prenatal vitamin
supplementation, therefore limiting the ability to detect
an association. Moreover, late pregnancy may not be
the period of a child’s development during which a
beneﬁcial effect of folic acid and multivitamins, is
critical to leukemia risk. However, this explanation
would not be consistent with observations from the
large pooled analyses of the Childhood Leukemia
International Consortium that showed reduced risksCurr Probl PediatrAdolesc Health Care, October 2016of ALL and AML associated with self-reported sup-
plementation during each trimester of the
pregnancy.138
Newborn and child serum-nutrient levels are inﬂu-
enced by many factors, including maternal and child
genetic polymorphisms.142 Many studies have found
signiﬁcant associations between single nucleotide
polymorphisms (SNPs) in folate-related genes, such
as MTHFR variants, and childhood leukemia; but,
there are inconsistencies in the speciﬁc SNPs that have
been identiﬁed across studies.140,143–147 A study exam-
ining the largest number of genes and SNPs in the
folate pathway found statistically signiﬁcant associa-
tions between SNPs in genes CBS, MTRR, and TYMS/
ENOFS (but not MTHFR) and childhood ALL.140
Levels of maternal folate intake during pregnancy,
and child’s Latino ethnicity were found to modify
some of these associations.140 Other studies, however,
did not report such interactions.144,148,149 Key ﬁndings
regarding folate intake and other vitamins are sum-
marized in Table 2.Topoisomerase II Inhibitors
The use of topoisomerase II inhibitors (a nuclear
enzyme involved in DNA replication) in cancer
chemotherapy has long been known to be associated
with common MLL gene translocations that are char-
acteristic of therapy-related AML.150 Consequently, it
was hypothesized that topoisomerase inhibitors may be
involved in the etiology of infant leukemia, because
this subtype commonly involves the same MLL gene
translocation that has been identiﬁed in these therapy-
related leukemias.151 Aside from chemotherapeutic
agents, topoisomerase inhibitors are found in diverse
sources, including herbal medicines, quinolone anti-
biotics, certain types of laxatives, and pesticides.152
Certain dietary sources also contain topoisomerase
inhibitors including, but not limited to, tea, coffee,
wine, and certain fruits and vegetables.152 Recent
laboratory studies, however, suggest that tea, wine,
and cocoa do not inhibit topoisomerase activity in vitro
and thus are unlikely to increase the risk of MLL
translocations.153
A small exploratory study examining maternal expo-
sure to topoisomerase inhibitors during pregnancy and
the risk of childhood leukemia found an increased risk
of AML with increasing topoisomerase II inhibitor
exposure (OR¼ 10.2; 95% CI: 1.1─96.4; N¼ 29 cases
for high exposure), but no increased risk for ALL337
TABLE 2. Association between folate and other vitamins and risk of childhood leukemia: selected case–control studies
Population No. of cases Source of vitamins Period of interest OR (95% CI)
Childhood Leukemia
International Consortium.138
6963 ALL Maternal supplement Prenatal Folate only
585 AML ALL: OR ¼ 0.80 (0.78, 0.92)
AML: OR ¼ 0.68 (0.48–0.96)
Any vitamins
ALL: OR ¼ 0.85 (0.80, 0.94)
AML: OR ¼ 0.92 (0.75–1.14)
Australia.139 333 ALL Maternal diet Pregnancy Folate
ORQ2 ¼ 0.68 (0.44, 1.06)
ORQ3 ¼ 0.58 (0.37, 0.91)
ORQ4 ¼ 0.44 (0.27, 0.71)
ORQ5 ¼ 0.70 (0.44, 1.12)
p-trend ¼ 0.05
B12 vitamin
ORQ2 ¼ 0.72 (0.47, 1.10)
ORQ3 ¼ 0.79 (0.71, 1.21)
ORQ4 ¼ 0.85 (0.71, 1.31)
ORQ5 ¼ 0.49 (0.71, 0.77)
p-trend ¼ 0.02
B6 vitamin
ORQ2 ¼ 1.04 (0.67, 1.62)
ORQ3 ¼ 1.15 (0.74, 1.81)
ORQ4 ¼ 1.28 (0.82, 2.00)
ORQ5 ¼ 1.60 (1.02, 2.51)
p-trend ¼ 0.03
California.141 681 ALL Maternal diet & supplements Peri-conception One-carbon metabolism
nutrients (i.e., folate, B vitamins)103 AML
ALL: ORPC ¼ 0.91 (0.84, 0.99)
AML: ORPC ¼ 0.91 (0.66, 1.04)
California.63 317ALL Blood levels Neonatal Hemoglobin concentration of folate at birth
44 AML No difference in between ALL, AML, and controls
ALL ¼ acute lymphoblastic leukemia; AML ¼ acute myeloblastic leukemia; Q ¼ quintile; PC ¼ principal component for one-carbon metabolism
nutrients.(OR ¼ 1.1; 95% CI: 0.5─2.3; N ¼ 82).151 Subsequent
studies conﬁrmed a positive relationship between
maternal dietary intake of topoisomerase II inhibitors
and risk of infant AML with a MLL gene translocation,
but have found no association between dietary intake
of topoisomerase II inhibitors and risk of other
subtypes of infant AML or any type of ALL.126,129
Coffee, Cola, and Tea
An early case–control study of 280 cases and 288
hospitalized controls found an increased risk of ALL
among children of mothers reporting coffee consump-
tion more than four cups a day during pregnancy
(OR ¼ 2.4; 95% CI: 1.3─4.7 for 4–8 cups; and
OR ¼ 3.1, 95% CI: 1.0─9.5 for 48 cups), with
similar ORs observed for acute non-lymphoblastic
leukemia that did not reach statistical signiﬁcance.154
Subsequent case–control studies have found maternal338consumption of coffee during pregnancy to be asso-
ciated with an increased risk of ALL, AML, and
possibly infant leukemia, while others have failed to
ﬁnd an association, as summarized in a recent meta-
analysis.155 There is some evidence from these studies
that the increased risk of leukemia with maternal
coffee consumption may be more pronounced among
children born to non-smoking mothers.156,157 Simi-
larly, cola-based drinks have been associated with
increased risk of childhood ALL (summary OR ¼
1.31, 95% CI: 1.09─2.47), while reduced risks have
been reported with maternal tea consumption during
pregnancy (summary OR ¼ 0.85, 95% CI:
0.75─0.97).155 A general limitation of those studies
is the lack of information on the type of drinks (e.g.,
caffeinated or not, green or black tea), which contain
different nutrients and other compounds with either
anti- or pro-carcinogenetic properties.Curr Probl PediatrAdolesc Health Care, October 2016
Alcohol
Maternal alcohol intake before or during pregnancy
has been hypothesized to inﬂuence childhood leukemia
risk by altering immune function or by teratogenic
effects on cell differentiation.158 Alcohol is also an
antagonist to folate metabolism and methionine syn-
thase and may modify DNA methylation status in
interaction with folate levels.159 A systematic review
and meta-analysis of 21 case–control studies found that
alcohol intake during pregnancy was associated with
AML (summary OR ¼ 1.56, 95% CI: 1.13─2.15Breastfeeding for six months or
longer, is associated with a
reduced risk of childhood
leukemia, whereas early
introduction to milk formula
may increase leukemia risk.produced from 9 studies
comprising 731 cases) but
not with ALL (summary OR
¼ 1.10, 95% CI: 0.93─1.29
produced from 11 studies
comprising 5108 cases).159
Heterogeneity between stud-
ies was explained in part by
some studies160,161 that dem-
onstrated a negative associa-
tion of childhood leukemia with maternal alcohol
consumption during pregnancy. Repeating the meta-
analysis by subgroup of alcohol indicated an increased
risk of AML associated with reported consumption of
wine but not beer or spirits, providing some additional
support for the topoisomerase II hypothesis.159 For
ALL, there was an association between maternal
consumption of spirits during pregnancy, but not beer
or wine.159 One subsequent study supported the ﬁnd-
ing of an increased risk of AML with maternal alcohol
consumption during pregnancy162 while another did
not ﬁnd an association156; neither found a relationship
between maternal alcohol consumption and ALL. In
contrast, two other recent studies found that maternal
consumption of alcohol during pregnancy was asso-
ciated with a decreased risk of ALL163 and of infant
leukemia.164Healthy Diet Index
In contrast to studies that have evaluated the role of a
limited number of speciﬁc nutrients or food compo-
nents, measures of overall diet quality may better
represent nutritional status and the complex biological
interaction of multiple nutrients.165 Diet quality indices
are often positively correlated with biological markers
of micronutrient intake and have been associated with
reduced risk of all-cause mortality, including cancer
risk.166,167 Maternal dietary patterns and quality haveCurr Probl PediatrAdolesc Health Care, October 2016also been associated with birth outcomes, such as
neural tube and congenital heart defects.168
In a recent study169 overall maternal diet quality, as
summarized by a diet quality index using a modiﬁed
version of the 2010 Healthy Eating Index, was
associated with a reduced risk of childhood ALL
(OR for each ﬁve point increase on the index ¼
0.88, 95% CI: 0.78─0.98). A more pronounced reduc-
tion in risk was observed among younger children and
children of women who did not use vitamin supple-
ments before pregnancy. There was a similar reducedrisk of AML with increasing
maternal diet quality score,
although this assosciation was not
statistically signiﬁcant (OR ¼
0.76, 95% CI: 0.52─1.11). No
single diet quality index compo-
nent (i.e., food group or nutrient)
appeared to account for the results,
suggesting that the quality of the
whole diet and the cumulativeeffects of many dietary components may be important
in inﬂuencing childhood leukemia risk.169Paternal Diet
In contrast to maternal diet, very few studies have
examined the relationship between paternal diet before
conception and childhood leukemia. One study sug-
gested that the risk of childhood leukemia increased
with increasing paternal consumption of hot dogs
(sources of carcinogenic compounds from N-nitroso
precursors).170 Also, there is no strong indication that
paternal intake of folate and other vitamins from diet
and supplements before the child’s conception reduced
the risk of leukemia in the offspring.171,172Child’s Diet
As mentioned earlier, breastfeeding and duration of
breastfeeding (6 months of more) have been associated
with the risk of childhood ALL, as summarized in
recent pooled173 and meta-analyses174 conducted by
the Childhood Leukemia International Consortium.
Besides breastfeeding, little is known about the inﬂu-
ence of child’s early diet. Feeding with formula as
early as 14 days after birth,175 alone or in combination
with breast milk, was associated with an increased
risk of childhood ALL and dose–response relation-
ships were reported for the duration of formula339
feeding.175,176 These studies contrasted previous null
ﬁndings.177 Infants and children fed with milk formula
have been found to have higher serum levels of IGF-1
than those breastfed, and fetal growth pathway has
been hypothesized to play a role in leukemogenesis.176
Associations between a child’s consumption of various
food groups and the risk for childhood ALL or for all
leukemias combined are inconsistent, especially
regarding the consumption of fruits and fruit juice, as
well as the consumption of meat.170,175,177–179 OlderIncreased risks of childhood
leukemia have been consistently
associated with exposures to
pesticides, tobacco smoke,
solvents, and trafﬁc-related
pollution.age at introduction to solid food
in general,176 and possibly
older age at introduction to
vegetables in particular,175 was
associated with an increased
risk of childhood ALL, while
a reduced risk was reported for
late introduction to eggs.175
Child’s consumption of cola-
based drinks does not appear
to be associated with leukemia, in contrast to maternal
consumption during pregnancy.155Conclusions
Most of the evidence to date supports the role of
prenatal folate supplementation, alone or with other
vitamins, in reducing childhood leukemia risk. Apart
from the possible beneﬁcial intake of fruits and
vegetables both during pregnancy and in the early
years of life, studies have led to mixed or isolated
ﬁndings regarding the potential leukemogenic effect of
other food groups, likely due to small sample sizes and
challenges of collecting accurate descriptions of par-
ticipants' diets. In addition, there has been relatively
limited consideration of the role of maternal diet on
risk of AML, a less common subtype than ALL.
Finally, measures of overall diet quality may represent
nutritional status and the complex biological interac-
tion of multiple nutrients better than single-nutrient
assessment, and should be used in future studies.A Clinical Perspective on
Environmental Health Literacy
Nurses, doctors, and other health care providers are
highly respected as sources for health information; as
such they play an important role in translating new
scientiﬁc ﬁndings to the public.180 It has long been340recognized that health care providers should act as
resources for information on environmental health for
their patients; unfortunately, U.S. medical education is
largely void of training in Environmental Medicine.181
Pediatricians and other providers report low self-
efﬁcacy in basic skills of Environmental Medicine
such as taking a history of environmental expo-
sures.10,182,183 A survey of members of the American
College of Obstetrics and Gynecology reported that
although three quarters of those surveyed agreed thatCurr Problcounseling patients could reduce
exposure to environmental haz-
ards, fewer than 20% routinely
discussed environmental expo-
sures—even known develop-
mental toxicants—with their
patients. Despite a lack of train-
ing in environmental health,
clinicians report a high interest
in learning more about currentenvironmental health research as it may apply to their
practice.10,182
Environmental Health Literacy is an evolving dis-
cipline that “combines key principles and procedural
elements from the ﬁelds of risk communication, health
literacy, environmental health sciences, communica-
tions' research and safety culture.”184 A basic level of
environmental health literacy will help clinicians to
have a sense of self-efﬁcacy about environmental
health and to fulﬁll roles as alert clinicians, educators,
and advocates for children’s health.
The key studies on environmental risk factors for
childhood leukemia are rarely published in clinical
journals and presentations on new environmental
epidemiologic research are rare at clinical meetings.
These circumstances require clinicians to make a
special effort to stay informed about the impact of
the environment on health. Fortunately, many online
resources are becoming available to make this easier
(Text Box 1).Childhood Leukemia: Is it Time for Primary
Prevention?
As presented in the preceding sections of this article,
there is a large and growing body of literature that
demonstrates the role of environmental agents in
determining the risk for childhood leukemias. This is
in contrast to other pediatric cancers that are more rare
and for which there have been far fewer environmentalPediatrAdolesc Health Care, October 2016
TEXT BOX 1–Online resources on environmental health literacy
for clinicians
1) Pediatric Environmental Health Toolkit online train-
ing. An introduction to the basics of children's
environmental health and approaches to anticipa-
tory guidance. Free continuing medical education
credits (http://www.atsdr.cdc.gov/emes/health_pro
fessionals/pediatrics.html).
2) A Story of Health. Multimedia e-book explores how
environments interact with genes to inﬂuence health
across the lifespan; includes a chapter on childhood
leukemia. Free continuing medical education credits
available from the CDC (http://wspehsu.ucsf.edu/for-
clinical-professionals/training/a-story-of-health-a-multi-
media-ebook/).
3) Little Things Matter. Video illustrates key concepts in
children’s environmental health (in multiple lan-
guages) (https://www.youtube.com/channel/UCbl
p9EePwfR8doGm9JbJOjA/videos).
4) Webinars, fact sheets, and other resources are
available from the Pediatric Environmental Health
Specialty Units, a network of experts in reproductive
and children's environmental health (http://www.
pehsu.net/health_professionals.html).epidemiologic studies conducted. The evidence impli-
cating environmental causes of childhood leukemia
comes from a variety of individual studies worldwide
and includes meta- and pooled analyses from the
Childhood Leukemia International Consortium, as
discussed in the Environmental Risk Factors for
Childhood Leukemia section. Exposures to agents such
as pesticides, tobacco smoke, solvents, and trafﬁc-
related pollution have been consistently linked to an
increased risk of developing childhood leukemia. On
the other hand, intake of vitamins and folate supple-
mentation during the preconception period or preg-
nancy has been associated with a reduced risk of
childhood leukemia as have breastfeeding and early
exposure to infection, as characterized by attendance at
large daycare and pre-school settings. Despite the fact
that many studies have identiﬁed modiﬁable risk
factors (increased or decreased risk) for childhood
leukemia we are aware of no current prevention
program that speciﬁcally addresses childhood leuke-
mia, anywhere in the world. The American Cancer
Society does support programs that discourage tobacco
use and promote healthy nutrition and exercise for
children, with the understanding that addressing these
factors early in life will reduce future cancer burden.1
Why is it that activities to reduce childhood leukemia
have not been incorporated into cancer prevention
programs when potentially modiﬁable risk factors haveCurr Probl PediatrAdolesc Health Care, October 2016been identiﬁed? Recently, our research group has
suggested that the time is right to develop activities
focused on primary prevention of childhood
leukemia.185,186What Evidence Is Needed Before We Take
Action?
Historically, there have been many chemicals for
which early warning signs of serious health impacts
have been ignored due to a lack of scientiﬁc consensus.
In some cases, protective efforts and corrective actions
were not undertaken until many years or even decades
after the ﬁrst trouble was spotted.187 For example, long
after initial concerns were raised about DDT, PCBs,
and lead, these chemicals continued to be used in large
quantities. While these chemicals were eventually
banned or restricted in use, in the interim they
continued accumulating in the environment, and left
a long-term legacy of detrimental exposures that were
unnecessary and avoidable.
The European Community recognizes the precau-
tionary principle, which provides justiﬁcation for
public policy actions in situations of scientiﬁc uncer-
tainly in order to reduce health threats. In contrast, in
the U.S., the regulatory framework generally requires
scientiﬁc consensus of proof of harm before policy
actions are carried out. The lack of public health
campaigns speciﬁcally focused on primary prevention
of childhood leukemia may, in part, result from this
tendency to avoid taking precautionary actions. In
clinical medicine, our mandate to “do no harm” often
dictates that we are wary of false positives, for
example, when interpreting results from a clinical trial.
However, in the context of environmental epidemiol-
ogy, it is also important to avoid making interpretations
that will yield false negatives, because a failure to
identify a hazard and take preventive actions poses a
threat to the public health.
At this time, despite steadily accumulating evidence
that environmental exposures increase the risk of
childhood leukemia, authoritative bodies, including
the International Agency for Research on Cancer
(IARC), consider only radiation and parents' active
smoking as “causative” factors in the development of
childhood leukemia. The Agency reviews individual
chemicals only periodically and many of the suspected
environmental risk factors for childhood leukemia
have not been reviewed in the last decade; a period341
TEXT BOX 2–The range of evidence suggested* as necessary to
validate public health action
1. Animal studies and toxicologic proﬁles
2. Human studies
3. Systematic structured reviews and meta-analyses
4. Prevalence of exposure to risk factor
5. Severe/dreaded outcomes
6. Risk beneﬁt or cost beneﬁt analysis
7. Likelihood of unintended consequences of potential
actions
8. Difﬁculty of sustaining intervention
9. Co-morbidities also associated with exposure
10. Mechanistic basis for health impact
*Adapted with permission from Holman and Bucha-
nan.185of time during which the environmental epidemiology
of childhood leukemia has developed substantially.
Clinical medicine has embraced an evidence-based
approach and uses systematic reviews (e.g., Cochrane,
GRADE) as the gold standard for determining the
quality of evidence. The highest quality of evidence
(within the evidence-based paradigm) is obtained from
double blinded, randomized trials, but this study design
would be impossible and unethical in the context of
childhood leukemia research on environmental expo-
sures. Prospective cohort studies, which generally are
thought to provide high quality of evidence, are
prohibitively expensive for a disease like childhood
leukemia with an incidence of less than 100 per million
population. Even an international effort to combine
existing mother–child cohorts leads to small numbers
of children diagnosed with leukemia and other cancers.
Studies assessing the role of environmental exposures
in childhood leukemia would almost exclusively be
given a lower quality of evidence rating, given that
they are usually, by necessity, observational studies
with case–control-designs. Adaptations of the system-
atic review methodology have been developed to
respond to the needs of environmental health and
may allow for more precautionary assessments in the
future.188,189
Primary prevention of cancer includes reducing
exposures to risk factors or changing the underlying
conditions which result in disease. While the CDC has
been exploring opportunities for early life prevention
of child and adult cancers, there are diverse opinions
about whether there is an adequate evidence base for
primary prevention of cancer.185 In a summary of
expert opinion on what evidence should be necessary342to support taking action, suggestions range from
animal studies and toxicologic proﬁles to high-
quality systematic reviews (Text Box 2).185Addressing Specific Evidence Needs for
Action
Many of the requirements suggested as a rationale for
undertaking primary prevention programs listed in
Text Box 2 have already been satisﬁed in the context
of childhood leukemia research. For example, many of
the risk factors identiﬁed in recent research are
common, resulting in widespread exposure to the
general population. Moreover, childhood leukemia
could certainly be considered “a severe and dreaded
outcome.” Though childhood leukemia treatment
results in an 80–90% cure rate, the treatment has
long-term health implications for those treated, as well
as profound impacts on the families and the commun-
ities who endure it. While most items on the checklist
for taking preventive action (Text Box 2) have been
completed, one notable exception is that, to date,
animal studies of leukemia have been limited, since it
is only recently that animal models of human child-
hood leukemia have been developed.190
Structured systematic reviews and meta-analyses are
viewed as key elements that support the validity of
ﬁndings from individual studies. Multiple meta-
analyses have been conducted on the most highly-
studied risk factors for childhood leukemia: pesticide
use, tobacco smoke, and trafﬁc-related air pollution. As
noted in the Environmental Risk Factors for Childhood
Leukemia section, the Childhood Leukemia Interna-
tional Consortium has investigated many of these key
risk factors for childhood leukemia using meta-
analyses and pooled analysis of original data from
case–control studies. These studies have been carefully
conducted and can be considered systematic reviews of
the epidemiologic literature.
Each factor in this issue that has been associated with
altered risk of childhood leukemia is also associated
with altering the risk of other health outcomes in
children as well as adults. In fact, these same exposures
that are implicated in the risk for childhood leukemia
have substantial documentation of their non-cancer
health impacts, including neurobehavioral deﬁcits and
respiratory disorders. Thus, acting to prevent childhood
leukemia would also reduce the incidence of other
diseases, and vice versa. These potential co-beneﬁts
should lessen any concerns that an error in attributionCurr Probl PediatrAdolesc Health Care, October 2016
TABLE 3. Examples of exposures associated with altered risk (increased or decreased) for developing childhood leukemia and. co-beneﬁts of improved
health outcomes by clinical and public health actions
Exposure Health impacts other than childhood
leukemia
Clinical recommendations Public health activities
Pesticides Neurobehavioral disorders, asthma,
adverse birth outcomes, adult cancer,
reproductive toxicity
American Academy of Pediatrics
recommends Integrated Pest
Management, exposure reductions.
Advocates clinicians become familiar
with acute and chronic/subclinical
effects and provide anticipatory guidance
Integrated Pest Management
recommended by U.S. EPA and
cooperative extension services
Tobacco Respiratory disease and asthma, adverse
birth outcomes, cardiovascular disease,
adult cancers, neurocognitive disorders,
sudden infant death syndrome
Smoking cessation, avoidance of
secondhand smoke universally
recommended
National and local tobacco control
programs, cessation hotlines
Air Pollution
(including
trafﬁc related)
Includes preterm birth, decreased birth
wt., asthma and respiratory
development, cardiovascular dis.,
neurobehavioral disorders
Less amenable to individual action.
Recommendations to restrict outdoor
activities during high air pollution days
(AirNow.gov). Avoid wood ﬁres.
Many programs for air pollution reduction.
Local programs to encourage walking
and biking. No idle zones, replacement
of old diesel vehicles. School siting
regulations.
Folate (risk
reduction)
supplementa-
tion/healthy
diet
Inadequate folate early in pregnancy
associated with neural tube defects,
increase in autism risk, other birth
defects
Preconception or prenatal folate
supplementation recommended by
American College of Obstetrics and
Gynecology and American Academy of
Family Physicians and others
Fortiﬁcation of supplementation
recommended by U.S. Preventive
Services Task Force
Breastfeeding
(risk reduction)
Sudden infant death syndrome, diarrhea,
bacteremia, otitis media, childhood
obesity, respiratory infection.204
Promote breastfeeding as the norm,
develop skills to assess and collaborate
with obstetrical community and certiﬁed
counselors, serve as advocates for
breastfeeding
2011 Surgeon General's Call to Action to
Support Breastfeeding: Actions for non-
governmental organizations,
government, employers, etc.
All states have breastfeeding coalitions,
programs to promote and support
breastfeeding in minority
communities.205would result in unwarranted actions with potential
negative impacts on health or increased ﬁnancial
burdens without beneﬁt to society. Moreover, some
high-risk behaviors—such as parental smoking—
already have clinical and/or public health recommen-
dations that attempt to alter exposure patterns.
Although these efforts are to be applauded, including
an additional focus on the potential of reducing child-
hood leukemia in these existing public health cam-
paigns may improve effectiveness. With the exception
of tobacco control and lead poisoning prevention,
efforts at wide-scale promotion of children’s
environmental health activities have received limited
funding and attention. When evaluating the costs and
beneﬁts of reducing exposure to an environmental
hazard, one must consider the total social and economic
impacts for risk reduction associated with all relevant
health outcomes (such as cancer, neurobehavioral
deﬁcits, and respiratory disorders). Examples of risk
factors and protective factors associated with childhood
leukemia, other co-morbidities associated with these
exposures, and current clinical or public health recom-
mendations relevant to these exposures are presented in
Table 3.Curr Probl PediatrAdolesc Health Care, October 2016Moving Toward Prevention
There have been rare instances when the conven-
tional American wisdom—that a determination of
causation is required before any action can be taken
to protect the public health—has been bypassed to
great beneﬁt. For example, in 1964, the U.S. Surgeon
General supported action to reduce tobacco use stating
Although the causative role of cigarette smoking in deaths from
coronary disease is not proven, the Committee considers it more prudent
from the public health viewpoint to assume that the established
association has causative meaning than to suspend judgment until no
uncertainty remains.191
Similarly, the “Back to Sleep” campaign sponsored
by the U.S. National Institute of Child Health and
Human Development to reduce sudden infant death
syndrome (SIDS) is another example of a highly
successful public health measure that has saved many
lives despite being adopted with less-than-uniform
agreement on causation.192 In 1992, the American
Academy of Pediatrics issued its policy statement
suggesting that infants be placed to sleep on their
backs or sides rather than prone.193 At that time there
were several case–control studies, but no prospective343
randomized clinical trials, to support the American
Academy of Pediatrics recommendation. Indeed, the
American Academy of Pediatrics statement acknowl-
edged many limitations in the epidemiological liter-
ature that was available for SIDS at that time. As
highlighted in the policy statement abstract
This recommendation is made with the full recognition that the existing
studies have methodologic limitations and were conducted in countries
with infant care practices and other SIDS risk factors that differ from
those in the United States (eg, maternal smoking, types of bedding,
central heating, etc).
In fact, the recommendation was in part informed by
ecologic studies, which is the study design that
generally provides the least convincing support forRisk factors for childhood leu-
kemia are also associated with
the risk of developing other
cancers, neurobehavioral deﬁ-
cits, and respiratory disorders.causality. These ecologic stud-
ies reported on SIDS inci-
dence following large-scale
changes in regional sleep posi-
tioning practice; observing
that when parents started put-
ting children to sleep in a
prone position the incidence
of SIDS increased.194 Subse-
quently, in 1994, the “Back to
Sleep” campaign was launched to discourage prone
sleeping for infants. By 2000, the U.S. mortality rate
for SIDS had dropped to one-half of the rate in 1990. A
set of additional recommendations aimed at decreasing
SIDS was included in the 2011 American Academy of
Pediatrics policy statement based on ﬁndings of vary-
ing scientiﬁc rigor.192
In making these policy statements, American Acad-
emy of Pediatrics adapted a strength of evidence
scheme from the U.S. Preventive Services Task Force
with a highest level of recommendation that requires
…good and consistent scientiﬁc evidence (i.e., there are consistent
ﬁndings from at least 2 well-designed, well-conducted case–control
studies, a systematic review, or a meta-analysis). There is high certainty
that the net beneﬁt is substantial, and the conclusion is unlikely to be
strongly affected by the results of future studies.
Many of the childhood leukemia risk factors listed in
Table 1 have multiple studies demonstrating their
effect and at least one meta-analysis if not a systematic
review. Moreover, at least for the environmental agents
that have been assessed via the comprehensive, pooled
analyses conducted by the Childhood Leukemia Inter-
national Consortium, it is unlikely that future studies
will contradict the current ﬁndings. Finally, when one
takes into account the multiple other diseases that are
also associated with these exposures, the beneﬁt of344taking public health action to reduce human exposure
should be considered substantial. Under the American
Academy of Pediatrics rubric noted above many of the
risk factors in Table 3 should receive the highest rating
for evidence quality.
Examples of Primary Prevention in Clinical and
Public Health Practice
Folate
As noted in the Dietary Risk Factors for Childhood
Leukemia section, adequate folate during the precon-
ception and very early pregnancy periods is not only
associated with reductions in the incidence of child-Curr Prohood leukemia but it also protects
against neural tube and other birth
defects and possibly
autism.195,196 In 1992, the U.S.
Public Health Service recom-
mended that all women capable
of becoming pregnant take
400 μg of folic acid daily. In
1998, the United States intro-
duced fortiﬁcation of enrichedcereal grain products with folate. It has been estimated
that folate fortiﬁcation has resulted in approximately
1300 fewer children being born with neural tube
defects, annually.197 Despite these dramatic results,
nearly one quarter of women of childbearing age in the
National Health and Nutrition Examination Survey
(2007–2012) were found to have suboptimal folate-
blood levels.198 In addition, Latinas were noted to have
signiﬁcantly lower blood folate levels than white
women. Given that Latino children—those living in
Central or South American as well as those living in
California—are recognized to be at greater risk of
childhood leukemia than white children, a public
health campaign targeting folate supplementation in
Latinas of childbearing age could be a particularly
important opportunity for childhood leukemia
prevention.
A caution would be a concern about the possibility of
some women exceeding the tolerable upper intake
level for folic acid. The National Health and Nutrition
Examination Survey estimated that 2.7% of partici-
pants (primarily women) exceed these recommended
folate values.199 Nonetheless, a careful emphasis on
improving nutritional status by ensuring fresh foods
and folic acid supplementation for women of preg-
nancy age seems warranted.bl PediatrAdolesc Health Care, October 2016
Tobacco
Although tobacco control programs and policies have
signiﬁcantly reduced smoking, there are still between
15% and 23% of young adult men and women who
smoke in the U.S.200 It is likely that most are not aware
of the link between paternal smoking around the time
of conception and a child’s subsequent risk of devel-
oping leukemia. To prevent soon-to-be-dads from
smoking before conception, fuller implementation of
proven tobacco control strategies aimed at preventing
smoking initiation and reducing smoking in teenagers
and young adults is needed.
Pesticides
Pesticide exposure, both prenatal and postnatal, has
been associated with leukemia risk. This supports
introduction of programs focused on the use of safe
pesticide practices during the preconception period. An
example of materials that target an audience of people
who are considering becoming, or currently are, preg-
nant is available from the Program for Reproductive
Health and the Environment at the University of
California, San Francisco. These include Pesticides
Matter: Steps to Reduce Exposure and Protect Your
Health (http://prhe.ucsf.edu/prhe/pesticidesmatter.html).
Preconception Care
Recently, reproductive health professionals
involved in the care and support of women of
childbearing age have begun to emphasize precon-
ception care. These professionals are interested in
including environmental factors as part of their
message to their patients about health promotion
before conception and during pregnancy.201 Including
both men and women in health promotion provides
an ideal opportunity to address environmental expo-
sures prior to early critical windows of development,
even before conception. Initial studies on the effec-
tiveness of strategies to promote behavior change to
reduce chemical hazard exposures preconception and
during pregnancy indicate that perceived normative
pressure (perception of what is common among peers
and important to family, friends and doctors) is a key
element.202 The U.S. Centers for Disease Control and
Prevention and the American College of Obstetrics
and Gynecology have begun programs to address
preconception health (http://www.cdc.gov/preconcep
tion/index.html, see Preconception Health and Health
Care). An effort should be made to ensure thatCurr Probl PediatrAdolesc Health Care, October 2016environmental health literacy and childhood cancer
prevention activities are addressed within the context
of these evolving programs and included in a new
standard of care.
The cancer prevention activities suggested by our
research on childhood leukemia and others203 largely
reinforce programs already in existence by different
public health entities (e.g., tobacco cessation, healthy
diet during pregnancy and folate supplementation,
avoidance of exposure to volatile organic com-
pounds, pesticides, and paint). Public health agencies
and health care systems can partner to extend
current programs with similar goals. Innovative
cross-agency, multidisciplinary program opportunities
include Enhance the use of news media and add risk
reduction for childhood leukemia to environmen-
tal health literacy education activities for the
general public, as appropriate. Include environmental health messaging in pre-
conception, prenatal, and child preventive health
care and as part of programs such as “Text
4 Baby” and “Bright Futures.” Assure that preconception health programs
include environmental health components and
additional emphasis on healthy diet. Use emerging systematic review methodologies
to evaluate environmental health risks with the
goal of having environmental health programs
recognized as evidence-based medicine. Improve health care provider counseling for
women and couples to integrate concepts of
environmental health—speciﬁcally the risk fac-
tors associated with childhood leukemia—into
medical education at all levels (during schooling
and post-graduate education) for nurses, physi-
cians, and allied health professionals. Develop policy initiatives to reduce exposures to
chemicals associated with childhood leukemia
(and other negative health outcomes) during pre-
pregnancy, pregnancy, and early childhood.The currently available toxicologic and observational
epidemiologic studies (including meta and pooled
analyses) provide a strong evidentiary basis for the
presence of casual associations (of small to moderate
sizes) between several environmental exposures and
childhood leukemia. Awaiting a more complete evi-
dentiary basis for decision-making, though ideal, will345
result in signiﬁcant delays in safeguarding children’s
health. Education of clinicians and the public on
primary prevention—actions that an individual can
take to reduce their own family’s exposures to chem-
ical risk factors for childhood leukemia as well as other
disorders—is something that can occur now. Ulti-
mately, regulatory actions based on the evolving
science are needed to shift the burden from the
individual to producers.References
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